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ABSTRACT
COM PARISON OF THE EFFECTIVENESS OF INTRADERMAL 
INJECTION OF LIDOCAINE, lONTOPHORETIC DELIVERY OF 
LIDOCAINE, AND TOPICAL EMLA CREAM  AS LOCAL 
ANESTHETICS FOR VENIPUNCTURE
By
Carol Straight
' T his s tu d y  w as un d ertak en  to establish w h e th er the adm inistration  of a local
anesthetic , lidocaine, significantly reduces the  p a in  of ven ipuncture  in  adu lts , to
i
g estab lish  the  deg ree  of tolerability and  effectiveness of each of three delivery
m eth o d s fo r Lidocaine, an d  to  identify  rec ip ien t's  preferences am ong the th ree  
pa in -re liev ing  m easures. In th is study , lidocaine w as adm inistered  using  th ree
d iffe ren t de livery  techniques: (1) in traderm al in jection of lidocaine, (2) ion tophor-
fs esis of lidocaine, and  (3) topical application of lidocaine/p rilocaine  cream , p rio r to
i u n d e rg o in g  ven ipunctu re . Partic ipants w ere  asked  to m easure the level of pa in
f,
I experienced  w ith  each m ethod  of local anesthesia  as well as the level of pa in
 ^ experienced  w ith  ven ipunc tu re  follow ing each local anesthetic. Each of the  th ree
I trea tm en t g ro u p s  w ere  com pared  w ith  placebo a n d  each participant served  as his or
\ h e r o w n  contro l. T w enty-tw o volunteers w ere  rec ru ited  for partic ipa tion  in  th is
Î s tu d y . T w en ty  vo lun teers com pleted tw o trea tm en t sessions and  tw elve vo lun teers
co m p le ted  th ree  trea tm en t sessions.
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CHAPTER ONE
INTRODUCTION
Pain elim ination an d  m anagem en t is one of n u rsin g 's  m ajo r responsibilities. 
Pain control is particu larly  im p o rtan t in  hospital settings w here  pa tien ts  frequently 
encoun ter uncom fortable p ro ced u res . O ne of the  m ost com m on  hospital proced­
ures is ven ipuncture . For th e  c lin ician w ho initiates v en ipunc tu re , the p rocedure  is 
seem ingly benign. To the rec ip ien t, a  ven ipunctu re  m ay be a n  uncom fortab le  and  
anxiety-provoking even t experienced  d u rin g  the hosp ital course.
In travenous cannu lation  is o n e  of a handfu l of invasive p ro ced u res  typically 
w ith in  the  sole dom ain  of nu rsing . N ursing  has historically  so ugh t-ou t caring and 
com fort m easures for patien ts, yet, has p roduced  lim ited research-based  rem edies to 
lessen the  aversion of in tra v en o u s  in se rtio n  (IV). There is a  substan tia l body of 
m edical research revealing the safety  and  efficacy of pain less o r  nearly-painlessy
 ^ v en ipuncture  using a local anesthetic  w ith  a host of d ifferen t de livery  techniques:
in d rad e rm a l injection, ion tophoresis, and  topical anesthetic  cream s.
D entists adm in ister m ore local anesthetics annually  th an  a re  g iven by all o ther 
m edical specialties com bined  (C hrigh ton , 1992). Pain-control is so fundam ental in 
den tistry  that a large p a rt of d en ta l train ing is ded icated  to local anesthesia. If one 
can  allow  an analogy betw een  th e  d iscom fort experienced d u rin g  too th  filling w ith  
the discom fort d u rin g  in tro d u c tio n  of a large-bore in travenous catheter, it is curious 
th a t m ost nursing  textbooks o n  IV therapy  only recom m end  h o ld in g  the skin taugh t 
as a m eans of reducing  pa in  (Dick e t al., 1992).
There m ay be several explanations for clinicians reluctance to use pain  reduc­
ing techniques d u rin g  IV insertion : (1) There m ay be a belief th a t venipuncture
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results in  little d iscom fort and  is well to lerated, (2) there m ay be a concern that use 
of a  local anesthetic exposes an  ind iv idual to po ten tia l allergic o r toxic reactions, (3) 
there  m ay be a belief th a t the  pain -reducing  in te rven tion  m ay p ro d u ce  g rea ter 
d iscom fort th an  the v en ip u n c tu re  itself.
Patients undergo  m any  painfu l p ro ced u res an d  are  frequently  u n d e rtrea ted  for 
their pain. R educing p a in  d u rin g  p ro ced u res  in  a n  effort to advocate for a p a tien t's  
w ell-being is a  crucial p a r t  o f the clinician 's role. H ow ever, the  topic o f p a in  
conjures such a w ide a rray  of genetic, cu ltu ral, a n d  social forces for b o th  patien ts and  
clinicians, the in ten t to  expel suffering is o ften  c louded . The biggest obstacle to 
elim inating  p ro cedu ra l-pa in  m ay be lacking com m unication  by  b o th  pa tien ts  and  
clinicians. Stoic silence in  the  face of p a in  is still v iew ed  as a  sign  of s tren g th  in  
m any  cu ltu res (d ted  in  Jaurez, 1997). C linicians engrossed  in  the technicalities of 
p rocedu res though t to  be  b rief a n d  m ild ly  invasive, m ay be com pletely  un aw are  of 
the ir p a tien t's  pain.
C ooperation  from  a n  a d u lt du ring  v en ip u n c tu re  is com m on as ad u lts  can  reason  
the  pa in  wiU be over soon. A sking a ch ild  to ho ld  his o r  h e r arm  sta tionary  d u rin g  
in sertion  of a needle is ask ing  behav io r con trad ic to ry  to h u m an  neurophysio logy .
s A ccording to sensory p a in  theory, w hen  a b u n d a n t nociceptors located in  the skin are
I stim u la ted  by p u nc tu re  from  a needle, fast afferen t sensory fibers (A fibers) carry  the
f-
I stim ulus to  the dorsa l h o rn  of the spinal co rd  w h ere  synapse occurs w ith  an  efferent
m o to r neuron . E fferent m o to r fibers rap id ly  trave l from  the spinal co rd  to the 
m uscle(s) of the  affected reg ion  causing re trac tio n  of the in jured  body  p a rt. This 
occurs instantly , before the  neosp ino thalm ic a n d  paleosp ino thalam ic tracts carry  the 
pa in fu l stim ulus to the  m idbra in , postcen tral g y rus, an d  cortex, w here  the  p a in  is 
realized  (Ludwig-Beym er, H uether, & Schoessler, 1994). If the specific p a in  stim ulus 
is repeated  o r perceived  as ex tra-ord inary , a  n ew  an d  p erm an en t pa in  reflex arc m ay
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be crea ted  (St. John, 1995).
N eu m an 's  System s T heory  describes env ironm en ta l forces o r stressors w ith  
w hich  ind iv idua ls strugg le. V en ipunctu re  is a  stressor p ro ducing  b o th  anxiety and  
pain . C on tend ing  w ith  such  stresso rs consum es an  in d iv id u a l's  energy  stores 
leav ing  less reserve fo r con tend ing  w ith  o th e r stressors. T he goal of nu rsing  
practice, according  to  N e u m an 's  System s T heory , is to  red u ce  o r  elim inate  stressors 
before  they  p ro d u ce  sym ptom ology  in  an  a ttem p t to  m axim ize an  in d iv id u a l's  
energy . N eu m an 's  T heory  subscribes to a  g rea ter level o f w ellness fo r an  ind iv idua l 
w h en  noxious env ironm en ta l stresso rs are  e lim inated  a n d  energy  reserves are 
h e ig h ten ed  (N eum an , 1989).
P u rp o se
This s tudy  w as u n d e rtak en  to establish  w hether the  adm in istra tion  of a local 
anesthetic , lidocaine, significantly  reduces the  p a in  o f v en ip u n c tu re  in  adu lts, to 
estab lish  the degree of tolerability  a n d  effectiveness of each  of th ree delivery  
m e th o d s for lidocaine, an d  to  iden tify  rec ip ien t's  preferences am ong the  th ree  pain- 
re liev ing  m easures. In  th is s tudy , lidocaine w as adm in istered  using  th ree  d ifferen t 
d e liv e ry  techniques: (1) in trad erm al in jection of lidocaine, (2) ion tophoresis of 
lidocaine, an d  (3) topical app lica tion  of lid o ca in e /p rilo ca in e  cream , p rio r to 
u n d erg o in g  ven ipunctu re . P artic ipan ts w ere  asked to  m easu re  the level of pa in  
experienced  w ith  each  m eth o d  of local anesthesia  as w ell as the  level o f p a in  
experienced  w ith  v en ip u n c tu re  follow ing local anesthesia.
T his research  s tu d y  is significant in  th a t it m ay dem onstra te  a safe an d  effective 
m ethod(s) for e lim inating  v en ip u n c tu re  pa in . A ccording  to N eu m an 's  System s 
T heory , elim inating  th is noxious stresso r w ill afford  an  in d iv id u a l a  g rea te r sense of
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w ellness. This s tudy  is the first step  in evaluating  tiie efficacy of infiltrated  lidocaine, 
ion tophoresed  lidocaine, and  topical lidocaine /p riloca ine  cream , as local anesthetics 
for a host of o th er pain-provoking  procedures experienced  by  pa tien ts  in both  
hosp ital an d  o u tp a tien t settings.
Safety and  efficacy of this study using an  a d u lt sam ple w as established. This 
s tudy  m ay serve to  be  p recurso ry  to fu ture  clinical trial(s) enrolling  hospitalized 
a d u lts  a n d  ch ild ren  u ndergo ing  m ultip le o r sequen tia l pa in -p rovok ing  m edical 
p rocedures.
CHAPTER TW O 
CONCEPTUAL FRAMEW ORK AN D LHERATURE REVIEW
C oncep tual M odel
Betty N eu m an 's  System s T heory is a nursing  m odel com m ission ing  the nurse 
w ith the responsib ility  to iden tify  an d  elim inate unhealthy  stressors. T he m odel 
describes the ind iv idua l as a dynam ic  and  open  system  in  constan t in te rac tio n  w ith 
both  in te rnal an d  ex ternal env ironm en ta l forces w hich  she  calls s tre sso rs  (N eum an, 
1995). C on tend ing  w ith  stresso rs consum es d ien t-system  energy. R espond ing  to 
stressors (resulting  in  asym ptom atic  an d  non-adap tational behaviors) a n d  reacting 
to stressors (resulting in  sym ptom atic  and  ad ap ta tional behaviors) is d ep en d en t 
u p o n  the  deg ree  of evo lu tio n  a n d  in tegration  am ong th ree  c lien t-system  
composites: (1) the  p e rso n 's  basic core w hich includes genetic m ak eu p , interrela- 
tional pa tterns, an d  energy  resources, (2) a m old of each in d iv id u a l's  physiological, 
psychological, sociocultural, developm ental, an d  sp iritual variables, a n d  (3) three 
m echanism s or lines of defense  pro tec ting  the client-system s' s basic co re  (N eum an, 
1989). N eum an 's  System s M odel is depicted  in  figure 1.
If the ou term ost flexible line of defense successfully "responds" to a  stressor, 
client-system  hom eostasis is p reserved . In  this case, a stressor w as th w a rte d  far 
before provoking  m anifesta tions of its ' presence (sym ptom s). If a  s tre sso r breaks 
th rough  the o u te r line of defense, the client-system  "reacts" an d  th e re  is conse­
quential sym ptom ology. A t th is p o in t the ad ap ta  tional norm al line o f  defense is 
activated m obilizing in te rn a l forces to  overcom e the stressor. If the  client-system  
effectively defends against the  stressor, "a ttainm ent" of a h igher level of resilient
5
THE NEUMAN SYSTEMS MODEL
Primary pr«v«nlion
« R educe possibility 
o f en c o u n te r  
w ith  stressors 
•  S tre n g th e n  
flex ib le  line 
o f d e fe n s e
Secondary prevention
•  E arly  case-fin d in g  
a n d
•  T re a tm e n t 
o f  sym ptom s
\
\
\
\
\
u
h-»- + 
I
I
. I
Stressors
•  Id en tified
•  C lassified  a s  to  Icnowns 
o r  possibilities, i.e .:
•  Loss
•  Pain
•  Sensory  d e p r iv a tio n
•  C ui:ural c h a n g e
Personal
focforl
Tertiary prevention
•  R é a d a p ta t io n  
« R eed u ca tio n  to
p re v e n t fu tu re  
occu rrences
•  M a in te n a n c e  
o f  stab ility
'K
Reaction
•  Ind iv iduel in te rv en in g  
v a ria b le s , i.e .:
# Basic s tru c tu re  
id iosyncrasies
# N a tu ra l a n d  le a rn e d  
res is tance
•  Time of e n c o u n te r  
w ith stressor
Stressor
X /
D egree j
reaction
Basic
structure
en e rg y
Reaction
Basic structure
•  Basic facto rs common 
to  all o rganism s, i.e .:
•  N orm al te m p e ra tu re  
ra n g e
» G en e tic  structure 
« R esponse p a tte rn
•  O rg o n  strength
•  W eakness
•  Ego structure
•  Knowns or 
com m onalities
Stressors
•  M ore th a n  one 
stressor could
occur sim ultaneously*
•  S om e stressor could 
v a ry  os to  im pact 
or reac tio n
•  N orm al d e fe n se  line 
vories with a g e  a n d  
d ev e lo o m en t
Interventions
•  C an  occur b e fo re  o r  a f te r  
res is tance  lines a r e  p e n e t r a te d  
in bo th  re a c tio n  a n d  
reconstitu tion  p h a se s
•  In terven tions a r e  b a s e d  on :
•  D eg ree  of re a c tio n
•  Resources
•  G oals
•  A n tic ip a ted  o u tco m e
Reconstitution
Could b e g in  a t  
an y  d e g re e  o r 
level of reac tio n  
R ange of possibility 
m ay e x te n d  b e y o n d  
norm al line o f d e fe n s e
Intro
Inter
Extra
Personol
factors
Figure 1. T he N eu m an  System s M odel as it appeared  in  1970. Perm ission  for 
rep rin t from  A pp le ton  & Lange Publish ing  C om pany.
hom eostasis occurs as the ind iv idua l has ad ap ted  o r acquired new  coping skills for 
th a t p a rticu la r stressor. If the no rm al line of defense falters, the innerm ost line of 
defense  called  the  the  line of resistance is activated . The line of resistance pro tects 
the  in d iv id u a l's  basic core by m obilizing in te rnal forces to overcom e the  stressor. 
O nce the s tresso r has been  arrested , the  client-system  m ay re tu rn  to  its ' form er level 
of hom eostasis w ith  the en v iro n m en t (m aintainm ent) o r the  client-system  m ay 
ach ieve a  h ig h e r functioning  level o f hom eostasis w ith  the en v iro n m en t 
(attainm ent). The degree of client-system  hom eostasis is the in d iv id u a l's  level of 
w ellness fo r th a t g iven tim e (N eum an, 1989).
A ccording to N eum an 's  System s Theory, the  goal of nursing  practice is to 
e lim inate  o r m odify  stressors, p referably  a t the flexible line of defense, in  o rd e r to 
conserve system 's energy for its m ost judicious use (Smith, 1990). Secondary 
in te rven tions a re  in tended  to e lim inate  stressors after sym ptom ology has occurred  
w hile  the  goal of tertiary  in te rv en tio n  is to  "re ta in"  the  in d iv id u a l's  cu rren t level of 
hom eostasis (wellness) o r "a tta in"  a h igher level of wellness.
V en ipunctu re  is a stressor. It provokes sym ptom ology, pain, therefore  it is a 
noxious s tim u lu s w hich has bypassed  the clien t-system 's flexible Une of defense and  
is opera tiona l a t the  norm al line of defense. Physiologic responses to  pa in  include 
an  increase in  h eart rate, b lood  p ressure , and  resp ira to ry  rate. A ddressing  the 
stresso r of v en ipunc tu re  a t th is junctu re  is secondary  in terven tion  accord ing  to 
N eu m an 's  System s M odel. As w ill b e  discussed in  m ore detail later, the  vasovagal 
trait, is an  id iosyncratic physiologic reaction to  p a in  w hereby there  is su d d en  and  
m ark ed  b rad y card ia  and  hypo tension  occasionally culm inating in  syncope. A t this 
junctu re , the  stresso r has ac tiva ted  the  ind iv idua l's  line o r resistance an d  is th rea t­
en ing  the in d iv id u a ls 's  basic genetic and  physiological core. T here is risk  of dam age  
to  cU ent-system  in tegrity  resu lting  in  a low er level of hom eostasis w ith  the
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Figure 2. In tegra tion  of N eu m an 's  System  M odel w ith  the Sensory Pain  Pathw ay.
In th is depiction, v en ip u n c tu re  is a stressor w h ich  initially  th rea tens the flexible 
line of defense w here  nerve  end ings (m eissner's corpuscles in  sk in  a n d  pacin ian  
corpuscles in  subcu taneous tissue) are  located. P rim ary  n u rsin g  in te rven tion  w ould  
elirninate v en ipunc tu re  p a in  before it h ad  sta rted ! W ithou t local anesthesia  o f 
these nerve endings, p a in  w ill occur along w ith  associated  sym p tom s includ ing  
increased heart rate , increased  b lood pressure , m uscle tension, an d  a sense of anxiety 
A t th is poin t, the  no rm al line  of defense has b e e n  ac tiva ted  as the  noxious pain  
stim ulus has been  tran sm itted  to the dorsal h o rn  o f the  sp inal cord . A n  efferen t 
m o to r response causes im m edia te  m uscle re trac tio n  o f the  body  p a r t  being  p u n c tu r­
ed. Secondary  n u rsin g  in te rven tion  such as verba l com forting  m ig h t he lp  in  
a tten u a tin g  the sym ptom s. A s the neosp inaltha lm ic  a n d  pa leosp inaltha lm ic  nerve 
fibers shoo t the p a in  stim u li to  pa in  centers in  th e  b rain , a  vasovagal reflex (genetic 
trait in  needle phobia) m ay be triggered. A t th is po in t, the in d iv id u a l's  line of 
resistance has been  activated . Tertiary nu rsing  is a im ed  a t p reven ting  syncope, o r 
restoring  hem odynam ic  stability  should  syncope occur.
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env ironm en t (wellness). See figure 2.
The N eum an  System s T heory describes an o th er key e lem en t o f the m odel 
called  the  created  env ironm ent. T he c rea ted  en v iro n m en t is a n  unconscious 
dep loym en t of all client-system  variab les in  o rd er to create a p p a re n t system  stability 
in  the  face of unm anageab le  adversity . T he created  en v iro n m en t offers tem porary  
p ro tec tion  for the  ind iv idua l b u t consum es considerable energy  in  the  process.
W hen  the  energy  sp e n t m ain ta in in g  th e  in d iv id u a l's  c rea ted  en v iro n m en t resu lts 
in  energy  deficits for o ther system  processes, the c rea ted  en v iro n m en t m ay m ove 
the  in d iv id u a l fu rth e r from  hom eosta tic  health . A n  in d iv id u a l's  c reated  env iron­
m en t can m anifest itself by changes in  response p a tte rn s  to stressors, for exam ple the 
use  of den ial (N eum an, 1989). As w ill be  p resen ted  later, th e re  is ev idence that 
phlebotom y, ven ipunctu re , an d  o th e r need le  associations, a re  so feared  by a segm ent 
o f the  popu lation , th a t rou tine  an d  e v en  com pelling m edical care  a re  avo ided  
(H am ilton, 1996). A ccording to  N eu m an s System s Theory, w h en  need le-fear leads 
to  avoidance behaviors and  d en ia l o f n eed  for hea lth  care, th e  client-system  m oves 
fu r th e r  from  hom eostasis w ith  the  env ironm en t.
E lim inating ven ipunctu re-associa ted  pa in  stops the  stresso r a t the flexible line 
of defense, p reven ting  pain  an d  it/s associated  physiologic m anifesta tions. For 
in fan ts an d  ch ild ren , e lim inating  ven ipunc tu re -assoc ia ted  p a in  m ay  p rev en t 
tem p o rary  o r p e rm an en t estab lishm en t of need le  phobias. E lim inating  ven ipunc­
tu re  p a in  p reven ts  em otional d istress w h ich  taps c lien t-system  energy  stores. 
C h ild ren  as w ell as adu lts  receiving v en ipunc tu re , a re  often  in  a  position  w here  it is 
stra teg ic  to spare  client-system  energy  for judicious use  opposing  m ore serious 
stressors. For victim s of need le  p h o b ia , e lim inating  v en ip u n c tu re  pain , elim inates 
a b a rrie r to regu lar health  care, a  necessary  ing red ien t for c lien t-system  hom eostasis. 
The follow ing is a rev iew  of the  lite ra tu re  exploring the  safety  an d  efficacy of local
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an esth esia  for v en ipunc tu re .
L ite ra tu re  R eview
A Belief T hat V en ipunctu re  is W ell T o le ra ted
It m ay  be a  com m on belief th a t fo r th e  v a st m ajority  o f persons, v en ip u n c tu re  
p ro d u ces only m inor d iscom fort an d  anxiety . H ow ever, it  is estim ated  th a t 10% of 
the  p o p u la tio n  is affected by  needle  phob ia , a  new ly  defined  m edical cond ition  
(H am ilton , 1995). N eedle fear, in  its sev erest form , resu lts  from  an  in h erited  
vasovagal reflex w hich  in  rare  cases has led  to  shock  an d  d e a th  (G alena, 1992).
M ore typically, needle fear p roduces tach y card ia  a n d  hypertension  follow ed by 
b rad y ca rd ia  and  hypotension  u p o n  n eed le  in sertion . T hese physiologic changes are  
\ accom panied  by  pallor, d iaphoresis, lig h th ead ed n ess , w eakness, syncope o r near-
% syncope (Engel, 1978).
I N eed le  fear is though t to  be  an  ev o lved  in h erited  tra it in  response  to  o u r
I
i species' h istory  of death  by piercing, stabb ing , a n d  cu tting  injuries. Skin p e n e tra tio n
i w o u n d s  are  p ro d u ced  from  teeth , claw s, a n d  tu sks of an im als as w ell as spears,
I a rrow s, sw ords, axes, knives and  bu lle ts  from  h u m an s (EUinwood & H am ilton ,
■ 1991). The corpus stria tum  is o u r species' m o st effective b arrie r against harm fu l
j ex te rnal stim uli. The absolute thickness of th e  co rp u s s tria tum  ranges from  1.0 to
I 2.0 m illim eters w ith  m ales hav ing  sightly  th ick er sk in  (C oats & L upin , 1995).
t
I T here  is evidence of a learned  c o m p o n en t to  need le  fear. In  one s tu d y  of 56
[ p ersons w ith  needle phobia, 52% traced  th e ir fea r to a  negative experience a t a
d o c to r 's  o r  d en tis t 's  office a t the  g ro u p 's  m e a n  age of 8 years. A no ther 24% 
experienced  vicarious conditioning  a t seeing  a n o th e r  ch ild , often  a sibling, d em on-
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stra te  a negative reaction  to needles (Ost, 1991). The fear of need les m ay becom e 
generalized to include  fear of need le-assodations such  as doctors, nurses, dentists, 
b lood, exam ination  room s, hospitals, a n d  even  the an tisep tic  o d o r  o f offices and  
hospitals (M arks, 1988).
N eedle fear is a  physiological a s w ell as psychological stressor. A long w ith  
a ltered  card iovascu lar hem odynam ics, several stress ho rm ones have  been  found  to 
rise d u rin g  need le  stim ulation . Increased  cortisol a n d  cortico trop in  levels have 
been  d ocum en ted  w ith  v en ipunc tu re  (Rose & H u rst, 1975). Serum  ep inepherine  
and  n o rep in ep h rin e  levels are  k n o w n  to  sharp ly  rise  th an  fall w ith  need le  
stim ula tion  (Taggert, R e d  w orth -W hitty , C arru thers, G ordon , 1976). A ntid iu re tic  
horm one (ADR) (EUinwood, 1991) a n d  renin , (G oldstein  e t al., 1982), becom e 
elevated  d u rin g  need le  insertion, w ith  A D R  rising as h igh  as forty  six tim es the 
norm al value. T hese rises are  p robab ly  secondary  to  the  decrease in  in travascu lar 
volum e associated w ith  the  m arked  b rad y card ia  an d  hypo tension  of the  vasovagal 
reflex.
N eedle fear m ay  serve as a b a rrie r  to receiving hea lth  care. Ind iv idua ls w ith
I need le  fear tend  to  avo id  health  care  even  w h en  the  n eed  fo r m edical a tten tio n  is?
com pelling. In  a su rvey  com pleted  b y  184 teenage w om en  after delivery , 22% 
adm itted  to d ifficulty  seeking p ren a ta l care an d  associated this to a  fear of having 
b lood d raw n  (C artw righ t et al., 1993).
W ith the incidence of needle p h ob ia  estim ated  to  be  10% of the  popu lation , it is 
h ighly  suspicious th a t a larger h id d e n  p opu la tion  m ay avo id  reg u la r hea lth  care 
secondary  to  fear o f need le  punctu re . T here  appears to be  ev idence  th a t needle 
insertion  m ay be m ore  th an  just a ro u tin e  and  ben ign  p ro ced u re  to  som e. The 
recognition an d  acceptance of need le  fear by  health  care p ro v id ers  is the  first step  in  
elim inating this po ten tia l stressor a n d  b a rrie r w ith in  o u r  hea lth  care system s.
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A Belief T hat A llergies o r  Toxicitv May O ccur W ith  the Use o f Local A nesthetics
Fear of exposing p a tien ts  to a potential d ru g  reaction  such  as a n  allergic 
reaction or system ic toxicity m ay  be ano ther com m on exp lanation  for the hesitancy 
by  clinicians to use a  local anesthetic  to a ttenuate  the p a in  associated  w ith  veni­
puncture . L idocaine is a  local anesthetic com m only u sed  since its release for use in 
m edicine and  d en tis try  in  1948. The chem ical nam e is 2-die thy  lam ino-N -2, 6- 
d im ethylphenyl-acetam ide. I t 's  m olecular stru c tu re  consists o f an  arom atic  ring, 
w hich is strongly  lipophilic , jo ined  by an  ester an d  a n itrogen-con tain ing  aliphatic 
chain  w hich is strongly  h y d roph ilic  (Costello, 1993). See figure 3.
□ NH -  CO  -  C H j -  N
Figure 3. Lidocaine m olecu le  having an  arom atic  ring, a n  ester, a n d  a liphatic  chain.
Lidocaine is m anu factu red  in a three-step process. 2, 6-d im ethylam ine is reacted 
w ith  chloroacetyl ch loride y ield ing  N-chloroacetyl-2, 6-xyladine. This in tu rn  is 
reacted  w ith  d iethy lam ine  to  form  lidocaine.
Local anesthetics of the  am ide  type are w eak  base so lu tions com prised  of 
charged an d  uncharged  particles. As the acidity  o f the am id e  anesthetic  increases, 
there is an  increase in  the a m o u n t of charged so lu tion  c rea ting  a m ore stable d rug  
w ith  a shelf life o f th ree  to  fo u r years. As the acidity  of the  so lu tion  decreases, there 
is a  greater uncharged  p o rtio n  of the solution, resu lting  in  a n  unstab le  form  easily 
subject to den a tu rin g  reactions such  as p h o to d eg rad a tio n  a n d  a ldehyde  form ation. 
Therefore, lidocaine hav ing  a  pK  of 7.4, has been  m an u fac tu red  w ith  an  ad justed  
p H  of 5.0 to 6.5 to  enhance shelf-life (PDR, 1995).
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There a re  a va rie ty  of com m ercially-prepared  single-dose an d  m ulti-dose vials 
available in  0.5%, 1%, 2%, a n d  4% streng th s of lidocaine for p e rcu tan eo u s an d  in tra ­
venous ad m in istra tio n . M ulti-dose  vials requ ire  the a d d itio n  o f a n  an tim icrobial 
agen t for p reserva tion . Typically, one  m illiliter of lidocaine con ta in s 1 m g of 
m ethy l-paraban  (MPF) for an tisep tic  p reservation . A llergies to  M PF are  rare  b u t 
know n. Single-dose vials of lidocaine can be obtained M PF-free. L idocaine so lu­
tions are  also availab le  w ith  ep ineph rine , a  vasoconstrictor, w h ich  w hen  a d d ed  to  
lidocaine, yields h ig h e r local tissue levels resu lting  in g rea te r d eg ree  and  d u ra tio n  
of anesthesia  (FDR, 1995).
The exact pharm aco logy  o f lidocaine is unclear. It appears  lidocaine inhibits 
ion flux a t the n e u ro n a l m em brane  in terfering  w ith  in itia tion  a n d  conduction  of 
im pulses. It is the  lipophilic  reg ion  of the lidocaine m olecule as w ell as the 
uncharged  po rtion  o f th e  d ru g  th a t is essential in  allow ing th e  m olecules to en te r 
the  neu ronal cell m em b ran e  o r  m yehn  sh ea th  w here  it exerts a  local anesthetic  
effect by  in terference w ith  ion  flux d u rin g  cellular depo lariza tion  (Costello, 1992).
The recom m ended  dosages for percu taneous adm inistration  o f lidocaine 
(w ithout ep inephrine) are  from  5 to  300 m g of a 0.5% o r 1% concentra tion . 
R ecom m ended dosag es of lidocaine g iven  percu taneously  in  ch ild ren  over th ree  
years of age are 1.5 to  2.0 m g ./lb . w ith  a m axim um  total dosage of 100 m g (FDR, 1995) 
Typically, in filtra tion  of am ide  anesthetics exert local anesthesia  from  5 to 15 
m inutes after in jection (C hristoph , B uchanen, BegaUa, Schw artz , 1988 an d  Farley, 
H ustead , Becker, 1994).
A pproxim ately  85% of L idocaine is m etabolized in  the live r th ro u g h  N -dealk- 
ylation. The b rea k d o w n  m etabo lites of lidocaine are m onoethy lg lycinexylid ide an d  
g lydnexy lid ide , w h ich  a re  less p o ten t th an  lidocaine, b u t still m ay  exert an  anesthet- 
tdc effect. The rem a in d e r of lidocaine is excreted intact by the  k idneys. The elim in-
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a tio n  of lidocaine is rap id  hav ing  a  half life of 1.8 hours w hen  adm in istered  in tra ­
venously . Renal dysfunction  does n o t ap p ea r to  effect the  pharm acology  of 
lidocaine . L iver dysfunc tion  m ay  p ro long  the  e lim ination  of lidocaine resu lting  in  
de layed  recovery  from  anesthesia. L idocaine crosses the b lood-brain  b arrie r an d  
p lacen tal b a rrie rs  by  passive d i ^ s i o n .  It has a p regnancy  class B rating  (PDR, 1995).
It is v irtually  im possible to d e te rm in e  the incidence of allergic or toxic reaction 
to lidocaine because th e  n u m b er of occurrences canno t be  eq u ated  w ith  the  ex tra­
o rd in a ry  n u m b er of usages of th is com m only-adm in istered  local anesthetic. It has 
been  described  th a t anesthetics of th e  am ide class are essentially free of sensitivities. 
H o w ev er, lidocaine has a rela tively  low  m olecu lar w eigh t (270.8) and  is therefore  
capab le  of com bin ing  w ith  a p ro te in  o r h igher m olecu lar w eigh t substance form ing 
a h ap ten e . A ny hap ten e  has the  capability  of anitigenicity  (A driana, Coffm an, & 
N aragh i, 1986). A lthough  it is im possib le  to quan tita te  adverse  reactions to lido- 
i caine, allergic reactions as a resu lt of sensitiv ity  to lidocaine ap p ea r to be extrem ely
rare  (FDR, 1995).
 ^ In  a rev iew  of 450 cases of adverse  reactions to lidocaine subm itted  to  a m anu-
; fac tu rer o f lidocaine from  1959 to  1975, only 41 of these cases could  be classified as
allergenic. A pproxim ately  one ha lf of the  allergenic cases w ere of the anaphylac- 
i. tic type  a n d  ten  w ere  d u e  to contact derm atitis . O ne h u n d red  an d  seventy  five cases
; w ere  actually  sym ptom s d u e  to  overdosage  of the  d rug . N inety  one cases w ere
i
i a ttr ib u te d  to psychophysiologic responses such as near-syncope d u rin g  a den ta l
i p ro ce d u re  a n d  one h u n d re d  an d  fo rty  th ree  w ere sym ptom s com pletely u n re la ted  to
f
; lidocaine (A drian i e t  al., 1986).
T hese sam e au th o rs  rev iew ed  the  lite ra tu re  perta in ing  to adverse  reactions to  
the  am id e  an d  ester g roups of anesthetic  agents from  1968 to 1984. D uring  this 
pe riod , th ir ty  fo u r cases of allergy  to  e ither am ides o r esters w ere  docum ented .
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O f these, 17 resu lted  from  the use of lidocaine an d  15 of these w ere  a  contact derm a­
titis reaction .
L idocaine has b een  used  nearly  50 years in  p rov id ing  effective local anesthesia 
for den ta l, m edical, and  surgical p rocedures w ith  a very  low  incidence of side effects. 
The to tal incidence of allergic reactions to lidocaine is less th an  0.05% (Dickey, 1988). 
O ther types of side effects (slurred speech, drow siness, hypotension) a p p ea r to be 
d o se -d ep en d an t an d  occur only w ith  serum  lidocaine levels in  the  toxic range of 5 to 
10 m eg /  m L. Serum  toxicity levels of lidocaine are  unachievable  w h en  adm inis­
tering  lidocaine locally in  the recom m ended  dosages (PDR, 1995). For exam ple, 
w h en  adm in istering  0.1 m l of a 1% solu tion  of lidocaine in traderm ally , it is 
equ iva len t to  adm in istering  only 1% of the  usua l load ing  dose  of lidocaine used in 
the m anagem en t o f cardiac arrhy thm ias (Dick e t al., 1992).
 ^ A Belief T hat A dm in istra tion  of a  Local A nesthetic  M ay P roduce  M ore D iscom fort
è T h an  V en ip u n ctu re  Itself
T here  are  th ree  m ethods of adm in istra tion  of lidocaine: injection, iontophor-
£
I esis, a n d  topical app lication . Some clinician 's believe the adm in istra tion  of these
i;
: local anesthetics (particu larly  injection) cause m ore  p a in  th an  v en ip u n c tu re  alone.
Som e clinicians u se  lidocaine injected subcutaneously  o r in traderm ally  over
f
’ the  v en ip u n c tu re  site  before  in travenous can n u laü o n  to e lim inate  th e  d iscom fort
I associated  w ith  th is p rocedure. H ow ever, m any  believe th a t there is equal or
I g rea te r d iscom fort p ro d u ced  by local injection o f lidocaine th an  tha t p ro d u ced  by
f in trav en o u s cannu la tion  itself. The follow ing is a rev iew  of the lite ra tu re
I com paring  d iscom fort p ro d u ced  by  local in filtration  of lidocaine com pared  to the
discom fort associated w ith  venipuncture.
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In traderm al In jection  o f L idocaine
In one study , d e p a rtm e n ta l anesthesiologists, believing th a t injection of local 
lidocaine before v en ip u n c tu re  w as unnecessary  if an 18 gau g e  o r sm aller cannula 
w ere  used , cannula ted  18, 20, an d  22 gauge Venflon in travenous catheters in  60 
a d u lt patien ts abou t to  u n d e rg o  surgery . T he pain  scores for these even ts w ere 
com pared  w ith  p a in  scores o f subcu taneous injection of 1% lidocaine alone, on the 
opposing  hand  of these  ind iv idua ls . F indings revealed  th a t IV insertions w ith  
cannulas of 18, 20, a n d  22 gauge  w ere  significantly (p < 0.006) m ore pain fu l than  
subcutaneous injection o f 1% lidocaine alone (H arrison, L angham , Bogod, 1992).
Dickey (1988) co llected p a in  scores from  31 adults d ra w n  from  a preoperative- 
day  su rgery  sam ple w h e re  each  g ro u p  w as assigned to e ither: in travenous cannula­
tion  w ith  in traderm al lidocaine , in travenous cannu lation  w ith  p lacebo  of sod ium  
chloride, or in trav en o u s can n u la tio n  alone. This doub le-b lind  s tu d y  revealed  low er 
p a in  scores for v en ip u n c tu re  w h en  lidocaine w as adm in istered  befo rehand  and 
g rea te r pain  scores for v en ip u n c tu re  w ithou t in traderm al lidocaine (p < 0.008).
A study  exam ining the  question , 'TDoes local anesthetic really  reduce the pain  of 
venous cannu lation  in  all sizes of IV catheters?" show ed th a t venous cannu lation  
w ith o u t in filtration  of lidocaine , w as significantly m ore pa in fu l th an  venous 
cannulation  w ith  lidocaine fo r sizes 18, 20, a n d  22 gauge cannu las (Langham  & 
H arrison , 1992).
It appears th a t su b cu tan eo u s o r  in traderm al infiltration of lidocaine decreases 
o r elim inates d iscom fo rt associated  w ith  ven ipuncture . T he question , how ever, is 
a t w h a t expense is th is b en efit gained? A lthough  used to  o b tu n d  pain , the  infiltra­
tion  of a local anesthetic  m ay  itself p roduce  p a in  (M orris a n d  W hish, 1984; M orris, 
M cKay, & M ushlin, 1987). T he d iscom fort associated wdth local in filtration  of
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anesthetics appears to be less and  p refe rred  by  patien ts w ho u n d erg o  in travenous 
cannu lation  (H arrison, L angham , & Bogod, 1992).
O ptim ally , subcu taneous o r  in trad e rm al in filtration  of local anesthetics w ould  
be painfree. T here have been  several approaches in  exarriirdng w ays to  reduce  or 
e lim inate th e  d iscom fort of local in filtra tion  of anesthetics. T he follow ing is a  
rev iew  of stud ies on  m ethods aim ed to e lim inate  the  d iscom fort associated  w ith  
local in filtra tion  o f lidocaine.
A double-blind, con tro lled  s tu d y  com paring  the levels o f p a in  associated w ith  
in traderm al and  subcu taneous in jection o f five d ifferen t am ide  anesthetics show ed 
that e tidocaine p ro d u ced  the  g rea test p a in  w ith  infiltration  w hile  lidocaine and  
chloroprocaine w ere ra ted  as the  least pa in fu l. B ipivacaine an d  m epivacaine 
p ro d u ced  relatively  in te rm ed ia te  levels of pa in . N either the  so lu tion  p H  nor the pK 
seem ed to influence the deg ree  of d iscom fort in  th is study. T he lip id  solubility of 
the so lu tion  m ost closely co rre la ted  the  pa in fu lness of the five anesthetics tested. 
(M orris et al., 1987).
A sim ilarly -structured  s tu d y  com pared  the  p a in  experienced  w ith  subcutaneous 
and  in trad erm al in filtra tion  of 1% lidocaine, 1% procaine, a n d  n o rm al saline in  20 
ad u lt volunteers. The resu lts revealed  th a t procaine, having  the low est p H  of 4.2, 
inflicted less pa in  com pared  w ith  th a t of lidocaine, having a p H  of 5.0. Lidocaine 
p rep a red  w ith  ad renalin  resu lted  in  g rea tes t d iscom fort w hile p la in  lidocaine 
exerted  slightly  m ore d iscom fort th an  th a t o f p rocaine. The d ifferences in  levels of 
pa in  betw een  all pa irs of solutions w ere  statistically significant a t  p  <  0.05 or better. 
(M orris & W hish, 1984).
Several stud ies d em o n stra te  th a t ad justing  the  p H  of lidocaine so lu tions to a 
near physiologic p H  of 7.0 to 7.4 resu lts in  less infiltration-associated discom fort 
(Farley e t al., 1994; C hristoph  e t al., 1988; S teinbrook, H ughes, F an d u llo , M anzi, &
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Ferrante, 1993; M ader, Playe, & G arb, 1993). C hristoph  e t al. found  tha t in  25 ad u lt 
v o lun teers , the level of p a in  associated w ith  in filtration  of am ide  anesthetics w as 
significantly  reduced  by  buffering  the  so lu tion  to near physiologic p H . T he 
in filtra tio n  of 1% lidocaine w as 4.5 tim es m ore  pain fu l th an  bu ffered  1% lidocaine 
a n d  1% m epivacaine w as 5.7 tim es m ore uncom fortab le  th an  bu ffered  1% 
m ep iv aca in e .
T he resu lts of this s tu d y  w as bolstered  in  a  double-b lind  trial w ith  a  larger 
sam ple  size of 184 adults. L idocaine buffered w ith  sod ium  bicarbonate  caused  
significantly  less p a in  u p o n  sk in  in filtration  th an  d id  1% lidocaine alone. There 
w ere  no  differences b e tw een  the  tw o groups wdth regards to p a in  a tten u a ted  in  
in tra v en o u s  cannu la tion  (S teinbrook e t al., 1993).
T here  m ay be ev idence th a t w arm ing lidocaine so lu tion  to bo d y  tem pera tu re  
m ay  red u c e  o r e lim inate th e  d iscom fort associated  w ith  subcu tan eo u s o r in trad e r­
m al in filtration  of an  am ide  anesthetic. Tw o stud ies w ith  sam ple  sizes of 25 each, 
d em o n stra ted  tha t w arm ing  lidocaine to 37 C an d  43 C respectively  resu lted  in  low er 
perce ived  levels of d iscom fort w h en  com pared  w ith  in filtra tion  of lidocaine a t a 
room  tem pera tu re  of 21 C (Gragg, Berbaum , & Smith,1987; D av idson  & Boom, 
1992). H ow ever, w hen  these  stud ies w ere repea ted  wdth larger sam ple  sizes (157 & 
40), there  w as no  statistical significance in the p a in  experienced  b e tw een  those 
receiv ing  room  tem p era tu re  or bo d y  tem pera tu re  in filtra tion  of lidocaine (Dalton, 
Sharm a, R edw ood, W adsw orth , T ouquet, 1989; M artin , Jones, W ynn, 1996).
A no ther app roach  in  reduc ing  discom fort of am ide in filtration  has been  
s tu d ied . D ilu ting  lidocaine a n d  m epivacaine in  balanced  sa lt so lu tion  (sim ilar to 
o ph tha lm ic  irrigating  so lu tion  containing N aC l 0.64%, KCl 0.075%, C aC l 0.03% N a 
aceta te  0.39%, an d  N acitra te  0.17%) p roduced  the  least a m o u n t o f d iscom fort up o n  
in filtra tion  w hen  com pared  to  lidocaine an d  m epivacaine  in  com m ercially  p rep a red
18
solu tions d ilu ted  in  no rm al saline. In this s tu d y , infiltration  discom fort ap p ea red  to 
be directly  rela ted  to the  acidity  of the anesthetic, p roducing  the least d iscom fort 
w hen the pH  ap p roached  a n  extracellu lar p H  o f 7.4 (Farley e t al., 1993).
The review  of the  lite ra tu re  p resen ted  d em onstra tes that (1) infiltration of the  
local anesthetic  lidocaine, w h en  buffered, is significantly  less painful than  
in filtration  of nonbuffered  lidocaine, an d  (2) local infiltration  of lidocaine reduces o r 
elim inates p a in  assoc ia ted  w ith  ven ipunctu re . 
lon tophore tic  D elivery  of L idocaine
A nother m eth o d  d esig n ed  to  deliver local anesthesia  is called iontophoresis. 
Iontophoresis is a  pain less m eth o d  of local in filtra tion  of anesthetics, w ith o u t the 
use of needles. Ion tophoresis is a  m ethod  of d riv ing  a local anesthetic, such as 
lidocaine, th rough  the sk in  by  app ly ing  a sm all electrical cu rren t to  the anesthetic  
solution. The electrical c u rre n t m u st have the  sam e po larity  as the dissolved 
m olecules of the anesthetic  solution. Since like-charges repel each other, the 
cu rren t drives the anesthetic  o u t o f so lu tion  a n d  into the  body surface th rough  
sw eat g lands in  the  skin  (C oats & Lupin, 1995). See figure 4.
Electrode^ ^ S o l u t i o n  of
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Figure 4. Iontophoresis o f positively-charged lidocaine m olecules across the skin.
The history of ion tophoresis da tes back  to 1879 w hen  M unck placed strychnine 
u n d e r a positive e lectrode  a ttach ed  to live rab b it skin an d  observed that the an im al 
d ied  of strychnine poisoning. In  1989, M orton  w ro te  a  book o n  cataphoresis o f ions
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into tissues. H e p laced  positively-charged g raph ite  p o w d er u n d e r a positive 
e lectrode a ttached  to his arm  w hich  p ro d u ced  sm all black spo ts u n d e r  his skin 
(Chein & Banga, 1989). H e also s tu d ied  the anesthetic  effects of iontophoresis of 
cocaine (G angarosa, 1983).
C on tem porary  app lication  of iontophoresis began  in  1959 w hen  Gibson an d  
Cooke adm in istered  p ilocarp ine by  ion tophoresis to induce sw eating  for diagnostic 
p u rposes in  cystic fibrosis (com m only called the sw eat test). Iontophoresis of lid o ­
caine w as first u sed  for anesthesia  for the hyperem ic e a rd ru m  (cited in  A rvidson, 
E rroth , H ansby , L indholm , W hitam -O lesson, 1984).
The princip les of ion tophoresis are  based  u p o n  the w ork  of the English chem ist, 
M ichael Faraday, w ho d iscovered  th a t liqu ids w ere  conductors of electricity. H e 
d iscovered  tha t rods, connected  to an  electrical pow er source, served  as electrodes. 
Faraday called the  rod  a ttached  to the  positive pole the anode  an d  the rod  attached  to 
i the negative  pole the cathode. H e w en t on  to find th a t w hen  an  electric cu rren t was
placed  in  certain  solutions, chem ical decom position  occu rred  resu lting  in  ions. Pos- 
I itively charged  ions w ere a ttrac ted  to the  negative rod  an d  negatively  charged ions
w ere a ttrac ted  to the  positive ro d  (Fay, 1989). L ater it w as found  th a t com pounds 
carried  th e ir ow n  electrical charges, hav ing  a specific conductiv ity  potential or 
■ polarity . Polarity  is m easu red  as positively  o r negatively charged . In  iontophoresis,
i positively  charged  m olecules such as lidocaine, wiU be d riv en  (repelled) across the
i
corpus s tria tu m  by w ay of sw eat g lands, sebaceous g lands, ha ir follicles, and
L
; open ings in  the junctu res of ep ithelial cells, w h en  a positive  electrical curren t is
I app lied  to  the so lu tion  (Chein, S iddiqui, Shi, Lelaw ongs, & Liu, 1988).
T he only  know n  s tu d y  of ion tophoresis of lidocaine in  evaluation  for its effect­
iveness in  a tten u a tin g  p a in  associated  w ith  v en ipunc tu re  w as conducted  in  1984. 
Sw edish  anesthesio logists rec ru ited  47 regu lar vo lun teer b lood  d o n o rs  in w hich 28
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persons received lidocaine a n d  18 received  3% sod ium  chloride  in  a double-b lind  
fashion. T w enty  one of the  28 receiv ing  lidocaine ra te d  venous cannu la tion  as 
com pletely painless w hereas 13 of 18 receiving placebo ra ted  their p a in  as usual. 
Because a p a in  scale w as no t u sed  in  th is  study, a  quan tita tiv e  com parison  w as not 
available (A rvidsson, e t al., 1984). F o u r years earlier, Russo, L ipm an, Com stock, 
Page, and  S tephen (1980) s tu d ied  th e  d u ra tio n  an d  d e p th  of anesthesia  fo r lidocaine 
adm in istered  by ion tophoresis, co m p ared  w ith  lidocaine in filtra tion , a n d  topical 
lidocaine. T w enty seven  subjects each  received the  th ree  m odalities a n d  anesthesia 
w as evaluated  by  p inp rick  w ith  a 21 gauge  needle every  5 m inutes u n til discom fort 
w as perceived. The m ean  d u ra tio n  o f anesthesia  w ith  ion tophoresis w as 14.5 
m inutes, w ith  in filtration  22.2 m inu tes, and  sw abbing 2.1 m inutes. E ach  subject 
u n d e rw en t su tu ring  of the  a rea  an d  rep o rted  pa in  in  a  categorical fash ion  of sharp  
pain , dull pain , an d  no  pa in . N o p a rtic ip an t rep o rted  sh a rp  p a in  a n d  one  person 
( rep o rted  dull pain.
! The anesthetic  effectiveness of iontophoresis of lidocaine in  derm ato logical
 ^ p rocedu res has been  s tu d ied . Sixty fo u r persons u n d erg o in g  injections, m inor
u*-
V
I incisions, cautery , laser trea tm en t, excisions, and  abrasive trea tm en t w ere
 ^ adm in istered  4% lidocaine w ith  ep in ep h rin e  by ion tophoresis. T he m ean  voltage
i; u sed  w as 3.4 m A  w ith  a m ean  d u ra tio n  of adm in istra tion  of 8 m inu tes. Overall,
; p a in  relief w as ra ted  as excellent by  51% of the patien ts, adequate  by  36%, and
i inadequate  by  14%. Those u n d erg o in g  excision fo u n d  ion tophoresis to  be  least
['■ effective. Iontophoresis w as 80 to  100% effective in  injections, ab rasions, laser
Ï
I surgery , and  cautery . O f 94 lon topho re tic  adm inistrations, 26 m ild ad v erse  effects
! w ere  noted. E ight w ere  p ro longed  e ry th em a a t the  site, in  9 instances, tingling,
stinging, or pulling  sensation  w as experienced. A m etallic taste  w as n o ted  by some 
receiving ion tophoresis o n  the  face (M aloney, B ezzant, S tephen, & P etelenz, 1992).
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T he effectiveness of ion tophoresis versus subcutaneous adm in istra tion  of 
lidocaine has been  s tu d ied  in  ch ild ren . T h irteen  ped ia tric  hem odialysis pa tien ts, 
ages rang ing  from  11 to  19 years, w ho  h a d  been  receiving dialysis for a t least one  year 
partic ipa ted . D ialysis requ ires tw o  in d ep e n d en t fistula insertions, therefore  each 
p a rtic ip an t served  as h is o w n  control. L idocaine 4% w as adm in istered  w ith  3m A 
for 10 m inu tes before the  first fistula cannu la tion  and w as again adm in istered  by 
subcu taneous in filtra tion  before  the  second  fistu la insertion. The visual analog  scale 
(VAS) w as used  to  m easu re  the  ch ild 's  perceived  level of pa in  d u rin g  application  of 
b o th  m ethods of anesthesia. In  add ition , th e  study  w as conducted  on  3 separa te  bu t 
sequen tia l dialysis trea tm en ts . A s w as hypothesized , the  adm in istra tion  of lidocaine 
by  ion tophoresis w as ra ted  b o th  least pa in fu l an d  least anxiety-provoking. H ow ever 
by the  th ird  session, p a in  scores for b o th  g roups had  nearly  m erged as perceived  pain  
fo r subcu taneou ly -adm in istered  lidocaine declined  over the  th ree  trials (2^1tzer, et 
al., 1991).
I T he effectiveness of ion tophore tic -delivered  anesthesia  has been  com pared  to
I top ical anesthetic  cream s in  derm ato log ie  practice. A double-b lind  contro lled  s tudy
I w as conducted  on  10 vo lun teers be tw een  the  ages of 26 a n d  37. T hree test sites w ere
p laced  o n  each forearm . A topical anesthe tic  cream  or contro l (m oisturizer) w as 
p laced  on  tw o sites of each  a rm  w hile  the  lontophoretic  u n it w as placed  on  the th ird
k
s tes t site  o f each a rm  w h ere  one site  de livered  10% lidocaine for a n  u n d o cu m en ted
\ a m o u n t of tim e, an d  th e  o th e r (placebo) u n it electrode p a tch  w as sa tu ra ted  w ith  10%
f of lidocaine as well, how ever the u n it w as tu rn ed  off. P inprick  to  the sites w ere
[ p e rfo rm ed  a t 30 m in u tes  an d  60 m inu tes a fte r the  anesthetics w ere applied . Pain
percep tion  w as ra te d  in  a  6 level categorical fashion. Both the  topical anesthetic 
cream  an d  ion tophoresis  p ro v id ed  anesthesia  g reater th an  the control. Io n to p h o r­
esis p ro v id ed  g rea te r anesthesia  th an  th a t of topical anesthetic  for b o th  30 m inu te
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and  60 m inute pinpricks (P = .001 and  P < 0.05 respectively). Iontophoresis prov ided  
com plete anesthesia for 8 of 10 subjects a t one h o u r a fte r app lica tion  while the 
topical anesthetic p rov ided  com plete anesthesia  to 1 of 10 a t this sam e in terval 
(G reenbaum  & Bernstein, 1994).
Clearly, there  have been  few  studies, w ith  sm all sam ple  sizes, exploring the 
efficacy of local anesthesia by iontophoresis. Of those conducted , d ifferent param e­
ters have been  stud ied . O ne explanation  for lagging research  m ay be the recognition 
tha t application of a d irec t cu rren t to  the skin  has, on  occasion, resu lted  in  m inor 
skin  b um s o r irritation . In the  s tudy  by A rvidsson, e t al., 5 o f 47 b lood donors 
developed m ild  ery them a a t the site of iontophoresis. O ne ind iv idua l from  the 
placebo g ro u p  developed  a bu rn ing  sensation in  this s tudy . R usso e t al. (1980) 
docum ented  sensations of w arm th , burn ing , o r cold in  8 and  stinging  in 6 of 27 
participants. G reenbaum  et al. (1994) docum en ted  no  side  effects to iontophoresis in  
10 subjects. M aloney, e t al. (1992) repo rted  ery them a in  8 of 26 ind iv iduals u n d er­
going iontophoresis. Z eltzer e t al. (1991) com pared  the efficacy of subcutaneous 
infiltration of lidocaine w ith  lontophoretic  de livery  of lidocaine in  a ped ia tric?
i dialysis sam ple. In  this trial transien t b lanching  and  e ry them a of application sites
I
f occurred w ith  bo th  m odalities. Tw o ch ild ren  w ere w ith d raw n  from  the s tu d y  after
I
j sustain ing cu taneous b u m s  d u ring  iontophoresis. The au th o rs  suggest one
explanation for the com plications seen in  this s tu d y  m ay be  th a t the  co rpus striatum  
\ is th inner in ch ild ren  an d  there  m ay be m ore po rous sw eat g lands, ha ir follicles, or
I ep iderm al cell junctions. A nother exp lanation  m ay be th a t u rem ia  in  ch ild ren
r requiring  dialysis p red isposes this popu la tion  to an  increased  risk  of skin injury.
! T here w ere no  episodes of cu taneous b u m s o r in jury  in  the  a d u lt popu lations
studied.
W hen sk in  injury does occur w ith  iontophoresis it is generally  considered  to be
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as a resu lt of electrolysis of sod ium  chloride p resen t in bo th  the skin and  e lectrode 
w hich  form s sodium  hyd ro x ide  u n d e r a positive  electrode and  hydroch loric  acid 
u n d e r  a negative electrode. C athodal (negative electrode) b u m s ten d  to  be the  m ore 
serious and  stud ies o f these reveal th a t hydrochloric  gas bubbles u n d e r the e lectrode 
have the effect of separa ting  ep iderm al cells. W hen this occurs, there  is an  increase  
in  flow  of cu rren t th ro u g h  the  ep iderm is (Leenung, 1970).
In addressing  the  p rob lem  of d irec t c u rren t skin injury as w ell as skin p erm e­
ability  resistance, a m eth o d  of transderm al period ic  ion to therapeu tic  system  (TPIS) 
has been  developed . W ith  th is technique, electrical cu rren t is tu rn ed  o n  an d  off 
system atically d u rin g  application , hav ing  the effect of cu rren t pulsations. This 
allow s discharge of electrical cu rren t from  th e  skin betw een  pulses, reducing  the  
reaction  form ing hydroch loric  a d d . In  add ition , perm eability  of d ru g  th ro u g h  skin 
is m ain tained  a t a m ore constan t ra te  (Chein e t al, 1989; O kabe, Yam aguchi, &: 
Kaw ai, 1987).
Review of the lite ra tu re  reveals th a t lidocaine delivered  by ion tophoresis is a 
viable m ethod  of anesthetic  delivery. The considerable advan tages of ion tophoresis 
in  th is text is its needlelessness an d  effectiveness in  p rov id ing  local anesthesia.
A dvantages of ion tophoresis including  o th e r applications have been  
sum m arized  by  C hein, S iddiqui, an d  Shi, (1990) as follows:
1. avoids the risks an d  inconvenience of p aren tera l therapy
2. p reven ts va ria tion  in  the  abso rp tion  a n d  m etabolism  as seen  in  oral ro u tes
3. reduces the in d d en c e  of over o r u n d e r  dosing  by continuous delivery  dose
4. perm its the use of a  d ru g  w ith  a very  sh o rt half -life
5. perm its rap id  term ination  of d ru g  shou ld  an  intolerance develop
6. perm its a  m eans fo r pa tien t-con tro lled  d ru g  adm in istra tion
7. ion tophoresis of lidocaine is a  reim bursab le  procedure
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P oten tia l d isadvan tages w ith  regard s to  ion tophoresis include:
1. p o ten tia l for m inor sk in  irrita tion  as w ell as m ore  serious cu taneous b u m
(w hen  skin  is com prom ised)
2. th e  am o u n t of tim e req u ired  for de livery  (typically 10 m in u tes  using  3mA)
3. th e  cost invo lved  (a typical ion tophoresis u n it costs $300 a n d  special 
filling electrodes, called m ed itrodes, a re  single-use an d  ob ta ined  only by 
m an u fac tu rers  of these devices
T opical Eutectic Lidocaine
T he  th ird  m ethod  o f adm in istering  a local anesthetic  is topical app lication . In 
1981, T he Sw edish  scientist, Fredrick Broberg, d iscovered  th a t w hen  crystalline 
am ide-type  anesthetics lidocaine a n d  p rilocaine w ere  m ixed, they  becam e a n  oily 
fluid. In  1983, The topical anesthetic  cream  (EMLA) w as ap p ro v ed  for m edical use. 
O ver the  last decade, topical anesthetic  cream s have becom e increasingly  p o p u la r  
for a tten u a tin g  pa in  associated w ith  v en ip u n c tu re  as w ell as o th e r m ino r 
derm ato log ical, otological, gynecological, an d  urological p ro ced u res  (Lee & R ubin ,
1993).
EM LA is an  acronym  for eutectic m ix tu re  of local anesthetics. T he te rm  eutectic 
refers to  the  pharm okinetics w hereby  the m elting  p o in t of tw o  anesthetics is low er 
w h en  th ey  are  com bined th an  w hen  alone. L idocaine a n d  p rilocaine a re  active 
am id e-ty p e  anesthetics w hich  w hen  alone are  crystals, b u t  w h en  com bined , form  an 
oil at 25 C  w hich  is then  em ulsified in  w ater. Each gram  of EM LA 5% cream  
contains lidocaine 25 mg., prilocaine 25 m g., polyoxyethylene ester 19 m g. 
(em ulsifier), carboxyethylene 10 m g. (thickener), sod ium  h y d rox ide  (adjusts p H  to  9), 
a n d  p u rified  w a ter (Astra Pharm aceutical, 1996). See figure 5.
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Figure 5. EMLA cream  contains b o th  lidocaine a n d  prilocaine in  eq u al p roportion .
Passive d iffusion  of d ru g  th ro u g h  the sk in  is called transderm al d ru g  delivery  
(TDD). TDD has been  ap p lied  to several com m only-prescribed m edications 
including estad io l-re leasing , nitroglycerin-releasing, c lonid ine-releasing , a n d  
scopolam ine-releasing system s (Chein, et al., 1989). EMLA cream  also relies on  the 
pharm acophysio logy of TDD. Skin consists o f the epiderm is, derm is, and  
subcutaneous tissue. The ep iderm is is com prised of five layers in  w hich  the 
ou term ost layer (stra tum  com eum ) is abou t 20% w ater an d  the innerm ost layer 
(stratum  germ inativum ) is 70% w ater. This is im p o rtan t in  th a t the  h igh  concen tra ­
tion of pu rified  w a te r in  the  em ulsion  (92%) assists penetra tion  o f the  d ru g  th ro u g h  
the relatively d ry  s tra tu m  co m eum  (FDR, 1996). As in  lidocaine so lu tion , there  are 
charged an d  uncharged  po rtions of EMLA em ulsion  w hereby the  unch arg ed  form  is 
responsible for p en e tra tio n  th ro u g h  the skin an d  the charged p o rtio n  is responsible  
for blockade of neu ro transm ission  (Buckley & Benfield, 1993). U nlike ion topho r­
esis technology, TDD system s do  n o t create g rea ter perm eability  by  a ltering  the 
o rganization  of ep iderm al cells. TDD is based u p o n  passive d iffusion  relying o n  the 
40 to 70 h a ir follicles an d  200 to  250 sw eat ducts contained  o n  every  square  
centim eter of no rm al skin (Chein, e t al., 1989).
A stra, the pharm aceutical m anufacturer of EMLA, recom m ends application  of 
a thick layer of th e  cream , 1 - 2  g ra m / 10 cm  (2 inches x 2 inches) o n  in tact sk in  a t  the 
site of ven ipunctu re . The a rea  is th en  covered  w ith  an  occlusive d ressing  m uch  like 
Tegaderm . A fter o n e  hour, the d ressing  is rem oved , the EMLA cream  w iped  off,
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and  the skin is then  p rep a red  as usual for v en ip u n c tu re  (A stra Pharm aceuticals, 
1996).
Lidocaine is a lm ost en tirely  m etabolized by  the  liver and  prilocaine is 
m etabolized equally  by  liver a n d  kidneys. System ic abso rp tion  of eutectic lidocaine/ 
prilocaine cream  has been  s tu d ied  and  appears to  be m inuscule. In general, 
m axim um  serum  p lasm a levels appear to be  10 to  100 fold  less than  concentrations 
considered to be toxic for these d rugs (Astra Pharm aceuticals; Juhlin e t al., 1989; 
Evers e t al., 1985). O ne study  evaluating abso rp tion  levels of lidocaine and  
prilocaine revealed th a t w hen  60 gram s is app lied  to 400cm of norm al skin  for 3 
hours, serum  lidocaine w as m easured  to be 1 /  24 of se ru m  toxic level for lidocaine 
an d  prilocaine w as m easu red  to  be 1 /  36 the se ru m  toxic level know n  fo r prilocaine 
(Astra Pharm aceutical, 1996). It has been fo u n d  th a t the  ra te  of absorp tion  (TTD) of 
EMLA cream  in to  subcu taneous tissue as w ell as vascu lature , m ay vary  according to 
the anatom ical location the cream  is applied  an d  the  cond ition  of the skin. Juhlin  et 
al. found  that EMLA is absorbed  m ore rap id ly  th ro u g h  facial skin  th an  skin of the 
forearm . W hen EMLA 5% w as app lied  10 g ram /100cm  to facial skin, m ean plasm a 
lidocaine and  prilocaine levels peaked 2 hours after application  w hich w ere
[ 150 m cg /L  and  58 m c g /L  respectively. W hen the  sam e dosage w as applied  to the
i
forearm , peak  serum  p lasm a level for lidocaine w as only  18 u g /L  5 hours after
;
\ application and  prilocaine w as undetectable in  serum  p lasm a (Juhlin & Evers, 1990).
It is recom m ended  th a t EMLA cream  be app lied  to intact, healthy skin. W hen 
EMLA w as app lied  to  psoriatic  lesions of 10 subjects, se rum  plasm a lidocaine levels 
one hou r la ter ranged  from  16 to 450 m cg /L . Prilocaine w as detectable in  7 of 10 
indiv iduals and  serum  concentra tion  levels in  these ran g ed  from  20 to 190 m cg /L .
It appears there is g rea te r variability  in  abso rp tion  a n d  serum  concentra tion  levels 
in  bo th  d rugs w hen  skin  is com prom ised  (Juhlin, H ag lu n d , & Evers, 1989).
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A bsorption levels of EMLA cream  have been  stud ied  in  ch ild ren . Ten gram s of 
lidocaine/p rilocaine  cream  w ere  app lied  to 10 sites on  10 ch ild ren  aged  2 and 3 years. 
Betw een 2 and  3 hours a fte r application, serum  plasm a concen tra tions for lidocaine 
and  prilocaine ranged  from  92 to 315 m cg /L  and  45 to  215 m c g /L  respectively 
(H augstvedt, F rim an, & D anielson, 1990). The recom m ended  doses by  A stra  
Pharm aceutical is 1-2 g ram s /  10cm for a d u ra tio n  of no  longer th an  2 hours. EMLA 
cream  is not recom m ended  for infants younger th an  3 m on ths of age.
EMLA cream  dem o n stra ted  no  teratogenic effects in  p reg n an t ra ts  w hen  applied 
22 tim es the usual dose  fo r hum ans (A stra Pharm aceuticals, 1996). H ow ever, no 
stud ies have been  co n d u cted  on  p reg n an t w om en, therefore, the  m anu fac tu rer 
recom m ends use  of EM LA cream  in p regnan t w om en  only if abso lu tely  needed.
L idocaine/prilocaine eutectic m ixture appears to be w ell-to lerated . Similar to 
its paren tera l co u n te rp art, topical lidocaine appears  to cause ra re  sensitivities or 
allergic reactions. Likewise, prilocaine is associated w ith  ra re  side effects.
The follow ing localized reactions w ere seen  in  1,500 pa tien ts  receiving EMLA 
cream : blanching o f sk in  37%, e ry them a 30%, ed em a  6%, p ru ritis  2%, a n d  rash  in 
less than  1% (A stra Pharm aceutical, 1996).
Bjerring e t al. (1989) s tu d ied  the  peripherovascu lar effects of EM LA in  9 healthy 
volunteers. Initially, b lanch ing  and  pa llo r w ere observed  at the  site of application at 
30 an d  60 m inute  in tervals, follow ed by  ery them a a t 2 hours from  application . This 
m ay reflect an  initial vasoconstriction  follow ed by  vasodilation. It is in teresting  that 
p lacebo cream  d em o n s tra ted  sim ilar findings. It is though t th a t the  occlusive 
dressing  used in  th is s tu d y  m ay have p layed  a ro le  in  the vascular response  
observed. H ow ever, w h en  this study  w as rep ea ted  w ith  a sam ple  size o f 50 healthy 
volunteers, b lanching  w as seen  in  66% of the  trea ted  g roup  a n d  in  only  6% of the 
placebo group. E ry them a occurred  in  34% of those receiving EM LA cream  and  2%
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in  those receiving placebo cream  (V illada, Z etlaoni, & Revxiz, 1990).
In  all clinical trials, the m ost com m on  side  effects, b lanching and  e ry them a at 
the site  of application, w ere tran sien t la s tin g  less th an  2 hours. EM LA cream  is so 
w ell to lerated  it has been  described  as p ro d u c in g  no  in terference w ith  w heal and  
flare responses in  in traderm al sk in  testing . In  this study , 36 o f 40 ch ild ren  received  
com plete  derm al anesthesia  d u rin g  sk in  tes tin g  (Wolf, Shier, L am pl, & Schw artz ,
1994).
T here has been  a single case o f m ethem og lob inem ia  in  a 3 m o n th  o ld  in fan t 
w ho  received 5 gram s of EMLA cream  to  the  back  of b o th  hands and  cubital regions 
for 5 hours. This in fan t w as also tak ing  su lfam ethoxazo le  80 m g da ily  for a  u rin ary  
trac t infection. For this reason, A stra  P harm aceu tica ls  w arns against the  u se  of 
ENILA cream  in infants an d  ch ild ren  rece iv in g  sulfa d ru g s  o r p e rso n s h av ing  
g lucose-6-phosphate dehydrogenase  defic iency  (G6PD). H em olytic anem ias have 
b een  kno w n  to occur w hen  persons h av in g  G 6PD  are  g iven  sulfa, m acro d an tin , 
ace tam inophen , n itrates, düan tin , q u in in e , d ap so n e , and  p h en o b arb ito i.
T he effectiveness of EMLA as a top ica l anesthe tic  has been w ell d o cu m en ted  in  
a g row ing  body  of clinical trials. M ost o f th e  clinical d a ta  on  EM LA cream  h av e  been  
genera ted  from  pediatric  popu lations. In  these  trials, p a in  w as q u an tita ted  by m eans 
of a verbal ra ting  scale o r v isual analog  scale (VAS). Partic ipants in  these  s tu d ies  
w ere  age th ree  m onths to seventeen  years. All trials w ere  double-b lind  a n d  placebo 
con tro lled . In  all stud ies involv ing  c h ild re n  u n d e rg o in g  ven ipunc tu re ,
EM LA cream  p rov ided  significantly g re a te r  p a in  relief th an  placebo (C lark & 
R adford , 1986; C ooper e t al. 1987; Joyce e t  al. 1993; K urien  et al. 1985; M oller, 1985;
[ Robieux e t al. 1991).
A pplication  of eutectic lidoca ine / p riloca ine  cream  u n d e r a n  occlusive d ressing  
can b e  inconvenient and  the precise d o sag e  ap p lied  m ay be questionable. To
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im prove application , a prepackaged, single use , p a tch  delivery  system  has been  
developed  w hereby  each patch  delivers 1 g of 5% eutectic  lidocaine/prilocaine. 
C linical trials thus far (Stew art e t al. 1992, R obieux e t al. 1992, C hang, e t al. 1993) 
have revealed  the  EMLA patch  to afford the  sam e effectiveness and  tolerability as 
a  local anesthetic  in  ven ipuncture , as p ro v id ed  b y  EM LA cream.
EMLA cream  has been  stud ied  in  adu lts  u n d e rg o in g  venipuncture. N o tt and  
Peacock (1990) fo u n d  there to be significantly less p a in  (px  0.005) w ith  ven ipunc tu re  
in  120 adu lts  w h en  EMLA cream  w as app lied  fo r 60 m inutes than  w ith  placebo for 
the  sam e tim e period . In a double  b lind  tria l o f  100 ad u lts  undergoing  veni­
p u n c tu re , b o th  p a in  relief and  ease of v en ip u n c tu re  w ere  found to be significantly 
g rea te r (p<0.001) a fte r 60 m inute application, w h e n  com paring  EMLA cream  to 
placebo (G unaw ardene & D avenport, 1990). M add i, H orrow , Conception, and  
M urray  (1990) investigated  the m ost efficacious app lica tion  in terval in 75 adu lts  
u n d erg o in g  ven ipunctu re . They found  45 to  60 m inu tes to be the m inim al effective 
app lica tion  tim e for EMLA cream  in  achieving  sign ifican t anesthesia  for 
venipuncture.
A ssessm ent of P a in
f A ssessm ent an d  m easurem ent of p a in  is com plex. Pain m ay be approached
i
? singularly , conform ed to  a po in t or a n um ber o n  a scale, o r pain  can be considered
I com pletely indiv idualistic  an d  unm easurable. A s best described by  M cCaffery (1972)
: 'p a in  is w ha tever the  experiencing person  says i t  is, and  exists w henever he says it
i does' (cited in  L atham , 1994).
It has been  w ell-docum ented  in  the  lite ra tu re  th a t stress and  illness can 
heigh ten  the  percep tion  of pain . It has also b een  w ell docum ented  that p re-p roced ­
u re  educa tion  reduce  b o th  stress and  d iscom fort associated  w ith  hospital p rocedures.
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There appear to be no  clinical investigations assessing the psychosocial 
influences w ith  regard s to  ven ipunctu re-associa ted  pain . A lthough  not d irectly  
m easured, the Zeltzer s tu d y  (1989) h in ted  to  operational self efficacy as p a in  scores 
for infiltration of lidocaine declined  w ith  each ad d itio n a l in trad erm al injection.
S u m m a ry
The litera ture  rev iew ed  appears to  overw helm ingly  su p p o rt the use of 
lidocaine as a safe a n d  effective local anesthetic  reducing  o r  e lim inating the pa in  of 
venipuncture . H ow ever, th ere  exist lim ita tions in  the  clinical trials p resen ted .
T here are few  clinical trials w ith  large num bers of partic ipan ts. S tudies ten d ed  to 
have enroUees as few as 7 u p  to  184. T here is a  lack of hom ogeneity  am ong the 
trials as different variables h ave  been  s tu d ied  (eg. d u ra tio n  of anesthesia, d e p th  of 
anesthesia, degree of anesthesia). Earlier s tudy  designs om itted  placebo and  
double  blinding  safeguards. M any d ifferen t p a in  assessm ent tools have been  used  in
f
I the past w ith  the Visual A nalog  Scale em erging  as the  p a in  assessm ent tool of
;•
i choice over the last decade.
I The review  of the  lite ra tu re  identifies several key areas for the  cu rren t s tudy  to
y address. A m ong clinicians, there  has yet to  em erge a  consensus as w h e th er o r no t to
I adm inister a local anesthetic  p rio r to ven ipunctu re . A n article  pub lished  in  the
j A m erican Journal of N ursing  "H o w  to Boost the  O d d s of a  Painless IV Start,"
I resu lted  in bo th  "ye" a n d  "ne" responses in  ed ito ria ls pub lished  by  the journal.
I W ith an  arsenal of safe a n d  effective pain-reliev ing  m easu res th ere  lacks an
f appreciation  for w hich  delivery  m easure  is m ost effective, m ost efficient, best
I tolerated, and  p refe rred  by  recip ients. If a  specific pain-relieving m easure  can be
repeatedly  identified as su p erio r w hen  com pared  to  o thers, there  m ay be a g rea ter 
likeliness for clinicians to  a d o p t this im p o rtan t practice. Ideally , pain-reliev ing
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m easures will som eday  be v iew ed of as a m enu  to be  selected from, best suiting the  
ind iv idua l rec ip ien t an d  the  situation.
Research H ypotheses
The hypo theses tested  in  this study  were: (1) anesthetic-associated pa in  will be 
ra ted  significantly  lo w er w h en  com pared  to ven ip u n c tu re  pain , (2) ven ipunctu re- 
associated p a in  will be  ra ted  significantly low er in  all th ree  trea tm en t g roups w hen  
com pared  to  placebo, an d  (3) ion tophoretically-delivered  lidocaine will em erge as a 
preference am ong the  th ree  treatm ents.
Three m utua lly  exclusive parts  of the s tudy  w ere  analyzed: (1) variances 
betw een  aU subjects, (2) variances due to trea tm en ts, an d  (3) variances w ith in  the 
subjects' response  to  th e  trea tm en ts. In add ition , resu lts o f the  questionnaire  show  
w hat percen tage of partic ipan ts  p referred  each trea tm en t as w ell as preferences for 
their ch ild ren .
D efinition  of Term s
In trad e rm a l In jection  is in filtra tion  into subcu taneous tissue  ju st below  the  skin. 
Small gauge need les (27 g) are  u sed  w ith  tuberculin  o r in su lin  syringes to deliver
0.5 m l of 1% lidocaine.
Io n to p h o resis  is a need leless infiltration technique w hereby  a 2% lidocaine so lu tion  
is p ropelled  th ro u g h  the  sk in  via sw eat ducts, h a ir follicles, an d  epithelial cell 
junctures, by  a tiny electrical cu rren t from  a b a tte ry -p o w ered  un it, p rov id ing  
local anesthesia  to a  sk in  d e p th  of 6 m m  w hen  using  3.5 m A  cu rren t for 7 m inutes. 
Eutectic L idocaine /P riloca ine  C ream  is an  em ulsion  con ta in ing  25 m g of lidocaine 
an d  25 m g o f p rilocaine as w ell as A rlatone (an em ulsifier), a  th ickener an d  d istilled  
w ater, w hen  app lied  topically , u n d e r an occlusive d ressing , for one hour, p rov ides
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local anesthesia  to a skin d e p th  of 2 m m .
P a in  is the  subjective pe rcep tion  of sensation(s) experienced a t the m o m e n t of each 
trea tm e n t a n d  a t the m om en t of v en ip u n c tu re . Each partic ipan t w ill d istill th is 
experience o n to  a m ark  o r p o in t p laced  a long  a 100 m m  visual analog  p a in  scale.
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CH A PTER THREE 
METHODOLOGY 
S tu d y  D esign
A quasi-experim ental, double b linded , design  w as used  to exam ine the 
re la tionsh ip  com paring  the  to lerability  o f th ree  delivery  m ethods for local 
in filtra tion  of lidocaine along w ith  th e  effectiveness in  a ttenuating  ven ipunctu re  
p a in  fo llow ing each m ethod  of anesthesia . T he s tu d y  enrolled  partic ipan ts w ho 
served  as the ir ow n  control. Each p a rtic ip a n t received th ree  different m ethods of 
local de livery  of lidocaine w hereby each  o f the  th ree  treatm ents (lidocaine by 
in tra d e rm a l in jection, lidocaine by  ion tophoresis, and  topical lidocaine/p rilocaine  
cream ) w as adm in istered  approx im ate ly  one w eek apart. The one-w eek in terval 
be tw een  trea tm en ts w as de te rm ined  sufficien t tim e to observe for local reactions 
an d  to  allow  for recovery of the trea ted  a rea  before subsequent treatm ents.
Sam ple a n d  Setting
T w enty-tw o healthy ad u lt m edical an d  param edical em ployees m et eligibility 
an d  vo lun teered  to partic ipate  in  th is  study . A vo lun teer sam ple of healthy  
in d iv id u a ls  w as im p o rtan t in de linea ting  o u t possible th rea ts to in ternal an d  
ex ternal valid ity  such  as em otional in fluences associated w ith  hospitalization, 
surgery , a n d  illness w ith  regards to th e  percep tion  of pain . It is acknow ledged that 
m edical and  param edical staff w ho v o lu n tee red  for participation  in  this s tudy  m ay 
possess a h igher th resho ld  for pa in  b y  v irtu e  o f their inform ed consent for u n d e r­
going m ultip le  ven ipunctures. It w as also  recognized  th a t m edical an d  param edical 
vo lu n teers  m ay  be m ore com fortable u n d erg o in g  invasive-type p rocedures w hen
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com pared  to a random ized  sam ple. Therefore, the results of th is s tu d y  m ay no t be 
assured ly  generalized  to the  general popu lation . These lim ita tions, how ever, w ould 
be expected to bias th e  resu lts  conservatively  w ith  pain  scores ten d in g  low er in  this 
sam ple w hen com pared  to p a in  scores ob tained  form  a ran d o m ized  sam ple  o r from 
an  inpa tien t hosp ita l sam ple .
Eligibility criteria:
1. English speaking  of age 21 to 55 years
2. A bsence of m ajo r o r chronic illness
3. Specifically, absence of cardiac, liver, k idney disease, o r G-6-P deficiency
4. N o kn o w n  allergy  o r sensitiv ity  to lidocaine
5. N o kn o w n  allergy  o r sensitiv ity  to prilocaine
6. T aking no  m edications w ith  the exception of n u tritio n a l supp lem en ts
7. Specifically, tak ing  no  sulfa d rugs
8. N o n -p reg n an t
9. N o u n u su a l sk in  d iso rd e rs
10. N o pacem aker o r  card iac im plantable defibrillator
11. A bsence of em otional o r psychological d isorder(s)
12. P rov ide  in fo rm ed  consen t
In stru m en ts
It is acknow ledged th a t th e  experience of pa in  is as ind iv idua l an d  un ique  as 
each hum an  being. G iven  th e  com plexity  of pain, there  can  be  n o  perfect assess­
m en t tool. H ow ever, if the effectiveness o f pa in -reducing  in te rv en tio n s p roposed  
in  th is study  are  to  be  ev a lu a ted , differences in  pa in  m ust be  m easu red . W ith  an
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apprecia tion  for this, the  s tu d y  used  a horizontal v isual analog  scale w ith  a leng th  of 
100 m m  to m easu re  th e  level of pa in  experienced  w ith  each  adm in istra tion  of 
lidocaine an d  w ith  each  v en ip u n c tu re  (See A p p en d ix  A).
The visual analog  scale (VAS) is a tool frequen tly  u se d  in  the  m easurem ent of 
pain . The tool w as first in troduced  by Keele in  1948 w h e n  he  p laced  the  w ords:
none— slight—m oderate— severe— agonizing
in  this fashion, a n d  asked  ind iv idua ls  to ra te  th e ir p a in  a long  th is verbal descrip to r 
scale (Latham , 1994). The tool has evolved to  a  sim ple  line, usually  100 m m  in 
length , w ith  p e rp en d icu la r lines a t each end  to  signify ex trem es of the  phenom ena 
u n d e r study . V erbal p ro m p tin g  can be  m in im al (no pain) ju st left o f the line and  
(w orst pa in  I can  im agine) to the  righ t of the line. O r there  m ay be verbal indicators 
spann ing  the  en tire  leng th  of the line m uch  like the  exam ple  above. Ind iv iduals 
a re  asked to place a  single m ark  along the line exem plify ing  the  level of pa in  they 
are  experiencing. This v isualiza tion  becom es quan tifiab le  w h en  the  distance 
betw een  the  left m arg in  of the  line and  the sub ject's  m ark  along the  line is m eas­
u red , y ield ing  a num erica l va lue  in  m illim eter un its .
C onstruct valid ity  (cited in  Gift, 1989; W ew ers & Low e, 1990) has been estab­
lished for the  VAS. Reliability for the VAS has been  as h igh  as .95 to  .99 in  assessing 
pa in  to as low  as .41 to .91 in  assessm ent of m ood. R eliability is g rea tes t w hen 
m easuring  in tersubjectly  an d  som ew hat low er w hen  sam p le  g ro u p s are com pared. 
Reliability rem ains h igh  (.95) fo r u p  to 24 h o u rs  b e tw een  p re te s t a n d  postest for pa in  
(cited in  W ew ers & Low e, 1990).
In  th is s tudy , each  pa rtic ip an t w as be asked  to  m ark  the  level o f their pa in  after 
each trea tm en t an d  a fte r each  ven ipuncture . P artic ipan ts w ere  in  a seated  position 
in  a  w ell-lighted area. Because there  w as a one  w eek  in te rv a l b e tw een  retests, partic-
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i p an ts  w ere  allow ed to v iew  their VAS sco res from  p rio r sessions as Scott and 
H usk isson  (1979) found  th a t pa tien ts  te n d e d  to  overestim ate  the  c u rren t pain  
experience w h en  prev ious scores w ere unavailab le .
T he Visual Analog Scales w ere  collected  from  partic ipan ts in  a m anner to 
en su re  com plete  anonym ity  from  the resea rch e r. T he VAS w ere  num bered  from  01 
to 22 an d  partic ipan ts w ere  asked  to m em orize  the  n u m b er o n  their VAS. The 
form s w ere  collected by  the reg istered  n u rse  adm in iste ring  the  trea tm en ts. O n  
su b seq u en t trea tm en t sessions, p a rtic ip an ts  collected the ir nu m b ered  VAS from  a 
pile. Follow ing the th ird  session, the  VAS w ere  collected by the  IV n u rse  and 
re tu rn e d  to  the  researcher. These m easu res w ere  in ten d ed  to m axim ize in ternal 
reliability.
P rocedures for D a ta  C ollection 
Eligible recru itm ents for this s tu d y  received  an  explanation  of the pu rpose  of the 
s tu d y  a n d  a tho rough  exp lanation  as to th e  m ethodo logy , tim eliness, an d  poten tial 
risks o f th e  s tu d y  ou tlined  th ro u g h o u t the  w ritte n  consen t fo rm  (See A ppendix  B). 
The consen t form  also in fo rm ed  the  can d id a tes  th a t partic ipa tion  w as com pletely 
vo lu n ta ry  a n d  partic ipan ts cou ld  w ith d raw  from  the  stu d y  a t any  time. Q uestions 
abou t the  m ethodology o r risks of the  s tu d y  w ere  elicited from  each candidate. O nce 
the  in d iv id u a l verbalized  u n d e rs tan d in g  o f the  s tu d y , he  o r she  w as g iven  the 
o p p o rtu n ity  to  voluntarily  partic ipa te  in  th e  s tu d y  b y  signing the  w ritten  consent. 
M eeting  # 1: In traderm al Injection w ith  L idocaine  Follow ed by  V enipuncture
A pproxim ately  tw o h o u rs  before ad m in istra tio n , th ree  m illiliters of 8.4% 
sod ium  b icarbonate  (N aH C 03) w as a d d e d  to  a  30 cc m ultidose vial of 1% lidocaine 
raising  the  p H  of lidocaine from  a range o f 5  to  6 to approxim ately  7.41 as m easured
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by a C om in g  p H  M eter M odel 345. N either the ad m in istra to r n o r recipient w as 
aw are  of w h e th er the  vial contained buffered lidocaine o r placebo of 0.9 sterile 
norm al saline as vials w ere  labeled "solu tion  1" an d  "so lu tion  2".
The antecubital aspect of one arm  w as cleansed w ith  70% alcohol. A  tuberculin  
syringe w ith  a 27 gauge needle w as used  to inject a  so lu tion  0.5 m l of 1% lidocaine 
an d  0.1 m eq  N a H C 0 3  intraderm ally  at a 5 degree angle to  the  skin, w ith  bevel 
up , over 3 to 5 seconds, form ing a w heal over the  an tic ipa ted  ven ipunctu re  sight. 
C annu la tion  of the  ve in  using a Insyte 20 gauge in trav en o u s catheter w as then  
carried  o u t. Im m ediately  following in traderm al injection an d  again  after IV cannu­
lation, pa rtic ipan ts  w ere  asked to evaluate  the in tensity  of pa in  associated w ith  each 
p rocedu re  by  p lacing a  m ark  along a 100 m m  VAS.
O n  the antecubital aspect of the opposing arm , the p rocedu re  w as repeated  as 
above, w hereby  a 27 gauge syringe w as used  to adm in ister 0.5 m l of unpreserved  
sterile  sod ium  ch lo ride  in traderm ally  and  cannu lation  of the  vein  using  an  Insyte 
20 gauge catheter w as carried  out. Following each  procedure , partic ipan ts w ere 
asked to m easure  the  in tensity  of pa in  associated w ith  each p rocedure  by placing a
i m ark  along  a 100 m m  VAS.
\ The in travenous catheter w as prom ptly  rem oved , ligh t p ressure  over the  sight
I m ain tained  for 10 seconds or until b leeding h ad  stopped , an d  a bandaid  app lied
Î w ith  in structions fo r rem oval in  tw o hours.
I Partic ipan ts w ere  observed for sym ptom s of allergic reaction  for 30 m inutes
I follow ing te rm ina tion  o f the last IV catheter. Partic ipan ts w ere rem inded  to contact
I the  researcher if sym ptom s such as redness, sw elling, o r p ru ritis  occur at the site(s).
i The researcher a ttem p ted  to contact each partic ipan t by  telephone approxim ately  24
hours fo llow ing trea tm en t to  evaluate for side effects.
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M eeting #2: Iontophoresis of L idocaine Follow ed by V enipunctu re
The lon tophore tic  un it used  in  this s tu d y  w as the N eed le  Buster M odel NB-1 
m anufactu red  by  Life-Tech. Inc. located in  H ouston , Texas. Iontophoresis w as 
applied  accord ing  to the m anu fac tu rer 's  guidelines. A pproxim ately  tw o m inu tes 
p rio r to adm in istra tion , each Life-Tech Inc. M editrode  w as filled w ith  2 cc so lu tion  
of 2% lidocaine. For the  opposing  arm  trea ted  w ith  placebo, approxim ately  tw o  
m inutes before  adm in istration , each M ed itrode  w as filled w ith  2 cc of sterile, 
unp reserved  sod ium  chloride. The con tainers w ere labeled "so lu tion  1" and  
"solution 2" to  ensure  b linding of the adm in istra to r an d  the  recipients.
The antecubital aspect of one arm  w as w iped  clean w ith  sterile 4 x 4  gauze. The 
Life-Tech Inc. M editrode  labeled "solu tion  1" w as p laced  u p o n  the  p rep a red  area. A n 
indifferent e lectrode w as affixed nearby. The u n it w as connected  to the electrodes 
and  a cu rren t of 3.0 m A m p w as app lied  for 8.3 m inutes for 9 indiv iduals, 7.5 
m inutes fo r 2 ind iv iduals, and  7.0 m inu tes for one ind iv idua l. Each recip ien t w as 
I asked if h e  o r she w as able to perceive the  curren t. If so, the  cu rren t w as titra ted
d ow nw ard  un til there  w as no  percep tion  of current. O ne rec ip ien t w as able to 
perceive cu rren t of 3.0 mA. The m A  w as g radually  decreased  to 1.5 m A and  the un it 
w as sh u t off a t 7 m inutes. The skin w as reexam ined  for breaks o r o ther im perfec­
tions b u t n o n e  w ere  found.
Follow ing treatm ent, the sk in  w as cleansed  w ith  70% alcohol and  cannu la tion  
of the vein using  a 20 gauge Ins}Te catheter w as carried  out. Im m ediately follow ing 
iontophoresis of the  solution, an d  again  a fte r ven ipunctu re , partic ipan ts w ere asked  
to evaluate  the  in tensity  of pa in  associated w ith  each p rocedu re  by placing a m ark  
along a 100 m m  VAS.
O n the  opposing  arm , the  p rocedure  w as repeated  as above w hereby the
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M ed itro d e  labeled "so lu tion  2" w as ap p lied . The iontophoresis u n it rem ained  in 
the  "off" position  for 8.3 m inu tes. T he sk in  w as cleansed w ith  70% alcohol an d  
cannu la tion  of the vein  using  a 20 gauge  Insyte catheter w as carried  ou t. Im m edi­
ate ly  follow ing iontophoresis, a n d  aga in  afte r ven ipuncture , p a rtic ip an ts  w ere 
asked  to evaluate  the in tensity  o f p a in  associated  w ith  each p ro ced u re  by  p lacing  
m ark  along alOO m m  VAS.
T he in travenous ca theter w as p ro m p tly  rem oved, light p ressu re  over the 
site  w as m aintained  for 10 seconds o r u n til b leed ing  had  s topped , and  a b an d aid  
ap p lied  w ith  instructions to  rem o v e  in  2 hours.
Participants w ere observed  fo r sym ptom s of allergic reaction for 30 m inutes 
fo llow ing term ination  of the  last IV catheter. Participants w ere  rem in d ed  to contact 
the  researcher if sym ptom s such  as b lanching , redness, sw elling, o r p ru ritis  
occur a t the site(s). The researcher a ttem p ted  to  contact the partic ipan ts b y  tele- 
 ^ p h o n e  approxim ately  24 h o u rs  fo llow ing trea tm en t to evaluate  for side effects.
M eeting  #3: Topical A pplication  of EM LA C ream
The eutectic lidoca ine /p riloca ine  cream  used  in this s tudy  wras EMLA 
m an u fac tu red  by ASTRA P harm aceu tica ls  located  in  W estborough, M ary land . 
EM LA cream  w as app lied  acco rd ing  the  the  m anufactu rer 's  instructions (See 
A ppend ix  D).
B oth the adm in istra to r a n d  rec ip ien t w ere  unaw are  of the  cream  u sed  as one
 ^ con ta iner w as labeled "cream  1" a n d  an o th e r container labeled "cream  2". An
t odorless, perfum e-free h a n d  lo tion , h av ing  the  sam e consistency and  color as EM LA
[ cream , w as used  for placebo.
2.5 g ram s of cream  labeled "cream  1" w as applied  to 2 inches by 2 inches of skin  
of the  antecubital aspect of one arm . A n occlusive T egaderm  dressing  w as app lied
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over the  cream . A fter the cream  h ad  been  m ain ta ined  for 60 m inutes, the  occlusive 
d ressing  w as rem oved  and  the  sk in  w iped  clean of the cream  w ith a sterile 4 by 4 
gauze.
Follow ing treatm ent, the  sk in  w as cleansed  w ith  70% alcohol an d  can n u ­
lation  of the  vein  using a 20 gauge Insyte ca theter w as carried  out. Im m ediately  
follow ing rem oval of the T egaderm  d ressing  a n d  again  after ven ipuncture , 
partic ipan ts w ere  asked to evaluate  the  in tensity  of pa in  associated w ith  each 
p ro ced u re  by placing a m ark  a long  a  100 m m  VAS.
O n the opposing  arm , the  p ro ced u re  w as repea ted  as above w hereby cream  
labeled "cream  2" w as applied , T egaderm  occlusive dressing  applied, and  th e  cream  
then  rem oved  afte r 60 m inutes w ith  a 4 inch  by  4 inch  sterile gauze. Follow ing 
trea tm en t, the sk in  w as cleansed  w ith  70% alcohol a n d  cannulation  of the  vein, 
using  a 20 gauge Insyte catheter w as carried  ou t. Im m ediately  following rem oval of 
the  T egaderm  dressing  and  ag a in  a fte r ven ipunc tu re , participants w ere a sk ed  to
I evaluate  the  in tensity  of pa in  associated  w ith  each  p ro ced u re  by placing a m ark
 ^ a long a 100 m m  VAS.
/
 ^ The in travenous catheter w as p ro m p tly  rem oved , light pressure w as m ain-
I ta ined  for 10 seconds or until the  b leed ing  h ad  stopped , and  a bandaid  app lied  w ith
in struc tions to rem ove in 2 hours.
Partic ipants w ere observed fo r sym ptom s of allergic reaction for 30 m inu tes 
follow ing rem oval o f the last IV catheter. P artic ipan ts w ere  rem inded  to con tac t the
Î
I researcher if sym ptom s such as redness, sw elling, o r p ru ritis  occur a t the site(s).
[ T he researcher a ttem p ted  to con tact each p artic ipan t by telephone approxim ately  24
t ho u rs  follow ing trea tm ent to  ev a lu a te  for side  effects.
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H u m an  Subject C on sid era tio n
Before d a ta  collection began, the p roposal w as subm itted  to G rand Valley State 
U niversity  H um an  R esearch R eview  C om m ittee  an d  to T he C hief Executive Officer 
and  a com m ittee of th ree  physicians of the M üliken M edical G roup. Each gave 
perm ission  to  p roceed  w ith  this clinical trial.
Expected risks to the partic ipan ts in  this s tudy  w ere an ticipated  to be extrem ely 
sm all if any. T here w as a 0.5% risk  for an  allergic reaction  to lidocaine o r prilocaine 
There w as an  estim ated  33% risk  for transien t b lanching  o r ery them a a t the treat­
m en t site(s) lasting less than  24 hours. T here m ay  be bru ising  of the  ven ipuncture  
site(s).
It w as unknow n  w he ther partic ipan ts w ould  develop  psychological or 
em otional anxiety  re la ted  to m ultip le  ven ipunctu res. H ow ever, there  have been  no 
such  ind ications in the lite ra tu re  p rom p ting  issuance. The tim e req u ired  by the
I pa rtic ipan ts  in  this s tudy  m ay have been  an  inconvenience. There w ere no expected
Ï benefits to the  partic ipan ts of this study . Follow ing com pletion  of the  study, one
I
I partic ipan t confided she had  had  a "terrib le fear" of needles resu lting  from  a "bad
[ experience w ith  an  IV" she had  received a t the age of sixteen. This partic ipan t sta ted
I en ro llm ent in  this s tudy  w as an  a ttem p t to "bea t the  fear" w hich she claim ed w as
I the case.
t
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CHAPTER FOUR 
RESULTS
T w enty subjects u n d e rw en t tw o trea tm en t sessions an d  12 of those partici­
p an ts  u n d e rw en t th ree  trea tm en t sessions. A total of 208 observations w ere 
m easured . In  trea tm en t 1, fou r p a in  scores w ere collected from  each of 20 subjects 
on June 6, 1997 for; (a) in traderm al injection of lidocaine, (b) ven ipunctu re  
follow ing in trad erm al in jection  of lidocaine (c) in tra d e rm a l in jection of sod ium  
chloride, (d) v en ip u n c tu re  follow ing in traderm al in jection  of sod ium  chloride. In 
trea tm en t 2, four pa in  scores w ere  collected from  each  o f tw elve subjects o n  June 13, 
1997 for: (a) ion topho re tic  adm in istra tion  of lidocaine, (b) ven ipunctu re  follow ing 
ion tophore tic  delivery  of lidocaine, (c) placebo for ion topho re tic  delivery  of lido­
caine, (d) ven ipunc tu re  follow ing placebo for ion tophore tic  delivery  of lidocaine. In 
trea tm en t 3, four p a in  scores w ere  collected from  each  o f 20 subjects o n  June 20, 1997 
for: (a) topical EM LA cream , (b) ven ipuncture  fo llow ing topical EMLA cream , (c) 
topical han d  lotion, (d) v en ip u n c tu re  follow ing topical h a n d  lotion. The observa­
tions for each trea tm en t an d  their placebo w as m easu red  using a 100 m illim eter 
V isual A nalog Scale. D ata  in  th is s tu d y  are  considered  in terval level.
Following the  first tw o  treatm ents w ith  ion tophoresis and  subsequen t veni­
punctu res, it becam e a p p a re n t tha t these partic ipan ts  m easu red  pain  scores for veni­
p u n c tu re  follow ing ion tophoresis h igher than  w as to  be  expected  a n d  in  these cases 
p a in  scores for v en ip u n c tu re  w ere  sim ilar to p a in  scores for ven ipunctu re  follow ing 
placebo. In  a  d iscussion  w ith  a technical su p p o rt rep resen ta tive  for Life-Tech., Inc., 
it w as adv ised  to  increase the  application  tim e to 15 m in u tes  starting  at 2 m A m ps 
an d  titra ting  the c u rre n t u p w a rd . The m an u fac tu re r 's  gu idelines recom m end 
app ly ing  2 to 4 m A m ps for 7.5 to  15 m inu tes for the  size m ed itrode  used  in this
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s tu d y . H ow ever, som e partic ipan ts , m ostly  physicians beh ind  in  th e ir  schedule  tha t 
day , w ere unable o r unw illing  to  a llow  for the p lanned  ion topho resis  of 7.5 m inutes 
an d  asked  to forego this session. T herefore, only 12 of the  20 p a rtic ip an ts  u n d erw en t 
th is trea tm en t session. Based on  to lerability  of ion tophoresis, n in e  in d iv id u a ls  
received  3 m A m ps cu rren t for 8.3 m inu tes an d  tw o ind iv idua ls  rece iv ed  3 m A m ps 
cu rre n t for 7.5 m inutes. O ne in d iv id u a l received  7.0 m inu tes of tre a tm e n t requiring  
titra tio n  of cu rren t d o w n w ard  to  1.5 m A m ps. The m ean  trea tm e n t tim e for the 
g ro u p  w as 8.07 m inutes. The m ean  cu rre n t for the g ro u p  w as 2.9 m A m ps.
The observations w ere p lo tted  an d  found  not to be  no rm ally  d is trib u ted . 
N onparam etric  statistics w ere app lied  in  the  analysis of the observations. The 
F riedm an  statistic  (nonparam etric) w as u sed  to m easure  variances w ith in  and  
be tw een  all th ree  trea tm en t g roups for the  12 participants. T he F ried m an  test 
de rives resu lts w ith in  95% accuracy  of its param etric  equ ivalen t. R ep ea ted  M easures 
A nalysis of V ariance (Glantz, 1992). T he W ücoxin Signed R ank te s t (nonparam etric) 
w as u sed  in  exam ining the 20 p a rtic ip an ts  undergo ing  only  tw o  o f th e  th ree  
trea tm en ts (this popu lation  arose w h en  8 of 20 partic ipan ts d id  n o t u n d e rg o  
trea tm en t #2 Iontophoresis of L idocaine). In this case, pa irw ise  com p arisons w ere 
m ade  betw een  trea tm en t g roups #1 (Injection of Lidocaine) an d  #3 (EM LA Cream ).
A Bonferroni Inequality  w as app lied  in  the analysis to co rrec t for m ultip le  
testing  on  tw o  separa te  and  sm all sets of da ta : (1) com parisons o f p a in  levels 
experienced  w ith  each d ifferent m eth o d  fo r delivery  of lidocaine, a n d  (2) 
com parisons of p a in  levels experienced  w ith  ven ipunc tu re  fo llow ing  each  of the 
th ree  treatm ents. A fter Bonferroni correction, a probability  of 0.02 o r  less w as 
d e te rm in ed  to  be "significant" (sufficiently low  to reject the  n u ll h y p o th es is  tha t 
none  o f the th ree  trea tm en ts w ill h ave  an  effect on v en ip u n c tu re  pain).
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O f the  22 volunteers, 20 participants com pleted  the study. O ne partic ipan t w as 
d ism issed  from  the stu d y  w hen  she d e m o n s tra te d  sym ptom s of d istress u p o n  
receiv ing  the  first trea tm ent. These sym p tom s included  su d d e n  a n d  new  
verba liza tion  of apprehension  regard ing  n eed le  punctu re , expressed feelings of 
w arm th , m ild  pa llo r an d  diaphoresis. T hese sym ptom s w ere b rief an d  w ith o u t 
sequelae. A no ther vo lun teer w as d ism issed  from  the study  w hen  she verbalized  
hav in g  h a d  a  local reaction  to an  im m u n iza tio n  in  the rem ote  past.
O f the  20 partic ipan ts com pleting the  s tu d y , 50% (n=10) w ere  fem ales, 40% (n=8) 
w ere  m ales, a n d  10% (n=2) w ere  un identified . T heir ages ranged  from  24 to 55 years 
w ith  a  m ean  age of 39.4 years. All pa rtic ipan ts  w ere  Caucasian. All ind iv idua ls  
w ere  m ed ica l o r param ed ica l em ployees v o lu n teerin g  partic ipa tion  d u rin g  th e ir 
no rm al w o rk d ay  in  the  conference /  lu n ch  ro o m  of the m edical b u ild ing  in w hich  
they  w ork .
H ypotheses T esting
[ T he hypo theses tested  in  this s tudy  w ere: (1) anesthetic-associated p a in  v v t I I  bef
ra te d  significantly  low er w hen  com pared  to ven ipuncture-associated  pain , an d  
(2) ven ipunctu re-associa ted  pa in  will be  ra te d  significantly low er in  all th ree  
trea tm e n t g ro u p s w hen  com pared  to placebo, a n d  (3) ion tophoretically -delivered  
lidocaine  w ill em erge as a preference am ong  th e  th ree  treatm ents.
C om parison  of Pain Betw een Local A nesthetic  and  Placebo 
C o m p ariso n  of In traderm al hijection of L idocaine w ith  Placebo
For in traderm al injection of buffered  lidocaine, pa in  scores ran g ed  from  0.0m m  
to 39.0m m  w ith  a m ean  p a in  score of 12.0m m. T he stan d ard  dev ia tion  w as 11.4mm. 
For in tra d e rm a l injection of norm al saline, p a in  scores ranged  from  3.0m m  to
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45.0mm w ith  a m ean  p a in  score of 20.0mm. The stan d ard  dev ia tion  was 12.5mm. 
There w as a sign ifican t difference in  perceived  pain  betw een  in traderm al injection 
of lidocaine a n d  in tra d e rm a l injection of no rm al saline w ith  in jection of buffered  
lidocaine resu lting  in  significantly low er p a in  scores (p = .0021).
C om parison of Ion to p h o re tic  Delivery of L idocaine w ith  Placebo
For ion topho re tic  delivery  of lidocaine, pa in  scores ranged  from  0.0mm to 
41.0mm w ith  a  m ean  p a in  score of 6.33mm. The s tan d ard  dev ia tion  was 12.4mm. 
For iontophoretic  d e liv e ry  of norm al saline, pa in  scores ran g ed  from  0.0mm to 
6.0nun w ith  a  m ean  p a in  score of 0.8. The s ta n d a rd  dev ia tion  w as 1.8mm. There 
w as no significant d ifference in  perceived p a in  betw een  ion tophoresis of lidocaine 
and  iontophoresis of p lacebo (p = .110).
C om parison of EM LA C ream  W ith Placebo
For app lication  of topical EMLA cream , p a in  scores ranged  from  0.0mm to 
17.0mm w ith  a m ean  p a in  level of 1.5mm. The s tan d a rd  dev ia tion  was 4.0mm. For 
application of EMLA placebo, pa in  levels ranged  from  0.0m m  to 52.0mm w ith  a 
m ean of 3.0mm. T here  w as no significant d ifference in  perceived  p a in  betw een the 
application of topical EM LA cream  and  the application  h an d  lo tion (p = .68).
C o m parison  of Pain Betw een A nesthetics
C om parison  of In jection  W ith Iontophoresis
W hen com paring  the pain  experienced w ith  injection of buffered  lidocaine 
w ith  iontophoresis of lidocaine p  = .80. Therefore, there  w as no  significant 
difference in  p a in  p erce iv ed  betw een  the  tw o de livery  techniques. The m ean pa in
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score for injection of lidocaine w as 12.0mm and  the m ean  p a in  score for iontophor­
esis of lidocaine w as 6.3mm.
C om parison  of In jection W ith  EM LA C ream
W hen com paring the p a in  experienced w ith  injection of bu ffe red  lidocaine 
w ith  topical EMLA cream  p  = .018. T herefore, there w as a  significant difference in 
pa in  perceived betw een  injection of lidocaine and  topical EM LA cream . The m ean 
p a in  level for injection of lidocaine w as 12.0mm a n d  the  m ean  p a in  level for EMLA 
cream  w as 1.5mm.
C om parison  of Ion tophoresis W ith  EM LA C ream
W hen com paring the  pa in  experienced  w ith  ion tophoresis of lidocaine to that 
experienced w ith  EMLA cream  p  = .034. Therefore, there w as n o  significant 
difference in the p a in  perceived  be tw een  these cinesthetics. M ean  p a in  levels for 
iontophoresis of lidocaine w as 6.3m m  a n d  the m ean  level fo r EM LA cream  was
f 1 .5m m .
Effects of Local A nesthesia  U pon  V en ipunctu re  Pain
Pain scores for ven ipunctu re  follow ing all trea tm en ts w ere  significantly low er 
than  p a in  scores for ven ipunc tu re  follow ing placebo. See su m m ary  of p a in  scores in 
Table 1 on page 49.
V en ipunctu re  Pain A fter In jection W ith  L idocaineI 
\
r Pain scores for ven ipunc tu re  fo llow ing in traderm al in jection  o f lidocaine
Î
ranged  from  0.0mm to 24.0m m  w ith  a  m ean  p a in  level of 7.1m m . T he standard  
dev ia tion  w as 7.1m m. Pain  scores for v en ip u n c tu re  fo llow ing in jection  w ith  
no rm al saline ranged  from  6.0m m  to  53.0m m  w ith  a m ean  p a in  level of 25.0mm. 
T he m ean  level of v en ip u n c tu re  p a in  using  placebo is m ore  th a n  th rice  th a t of
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ven ipunctu re  pain  w ith  anesthesia. W hen  com paring v en ip u n c tu re  pa in  w ith  
injected lidocaine to v en ip u n c tu re  p a in  w ith  injected placebo, p  = .001. Therefore, 
there  is significantly  less d iscom fo rt w h e n  v en ipunc tu re  is p re tre a te d  w ith  injected 
lidocaine w h en  com pared  to v e n ip u n c tu re  p re trea ted  w ith  placebo.
V en ipunctu re  Pain  A fter Ion to p h o resis  o f L idocaine
Pain scores for v en ip u n c tu re  fo llow ing iontophoresis of lidocaine  ranged  from 
5.0m m  to 38.0m m  w ith  a  m ean  p a in  level o f 15.4mm. T he s ta n d a rd  d ev ia tio n  was 
10.0mm. Pain  scores for v e n ip u n c tu re  follow ing ion tophoresis of p lacebo  ranged  
from  3.0m m  to  61m m  w ith  a  m ean  p a in  level of 29.5mm. T he s ta n d a rd  dev ia tion  
w as 19.6mm. The m ean  p a in  score  fo r v en ip u n c tu re  w ith o u t io n to p h o resis  was 
tw ice the m ean  pa in  score w ith  anesthesia  b y  iontophoresis. In  co m p arin g  veni­
p u n c tu re  p a in  w ith  and  w ith o u t ion tophoresis , p  = .0053. T herefore , there  is a 
significant red u c tio n  in  v e n ip u n c tu re  p a in  w ith  ion tophoresis o f lidoca ine  w hen  
com pared  to  v en ipunc tu re  p a in  fo llow ing  trea tm en t w ith  p lacebo.
V en ipunctu re  Pain A fter A pp lica tion  of EM LA Cream
Pain scores for v en ip u n c tu re  follow ing EMLA cream  ran g ed  from  0.0m m  to 
60.0m m  w ith  a m ean  p a in  level of 6.3m m . T he s tan d ard  d ev ia tio n  w as 6.7m m .
Pain  scores for ven ipunctu re  fo llow ing  application  of p lacebo  ran g e d  from  4.0mm to 
60.0m m  w ith  a m ean  p a in  level of 27.3nun. The m ean  p a in  score  fo r v en ipunc tu re  
follow ing p re trea tm en t w ith  h a n d  lo tion  w as over q u a d ru p le  th a t of the  m ean  pain 
score w hen  EM LA cream  w as u sed . In  com paring  v en ip u n c tu re  p a in  b e tw een  the 
use  of EMLA and  placebo, p  = .0001. T herefore, there is a significant red u c tio n  in 
p a in  experienced  w ith  v en ip u n c tu re  p re tre a te d  w ith  EMLA cream  w h e n  com pared  
to  v en ip u n c tu re  p re trea ted  w ith  p lacebo.
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Table 1. The Influence of T reatm ents U p o n  M ean V enipunctu re  Pain  Levels
50
45
Pain 40
in
M illim eters 35 
(100m m  VAS)
30
T reatm ent
Placebo
25
20
15
10
5
0
n=20 n=12 n=20
Injection Iontophoresis EMLA
M ethods of A dm inistra tion  o f L idocaine and Placebo
C om parison  o f V en ipunctu re  P a in  B etw een  A nesthetics 
C om parison  o f In jection  W ith Ion tophoresis
W hen com paring  m ean  levels of p a in  fo r ven ipunctu re  follow ing in jection  of 
lidocaine an d  m ean  p a in  levels for v e n ip u n c tu re  follow ing ion tophoresis of 
lidocaine p  = .0422. T herefore, there  is no  significant difference in  v en ipunc tu re  
pa in  w hether there w as pretreatm en t w ith  injection o r iontophoresis of lidocaine.
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C om parison  o f Infection W ith EMLA C ream
W hen  co m p arin g  m ean  pain  levels fo r v e n ip u n c tu re  fo llow ing in jection of 
lidocaine w ith  m ean  p a in  scores for v en ip u n c tu re  fo llow ing trea tm en t w ith  EMLA 
cream  p  = .787. T herefore, there is no significant d ifference  be tw een  ven ipunctu re  
pa in  w h e th e r i t  is p reced ed  by injection o f lidocaine  o r  app lica tion  of EMLA. 
C om parison  o f Ion topho resis  W ith EM LA C ream
W hen co m p arin g  m ean  pa in  scores fo r v e n ip u n c tu re  follow ing iontophoresis 
of lidocaine a n d  app lica tion  of EMLA cream  p  =  .18. Therefore, there  w as a 
significant d ifference  in  p a in  perceived w ith  v en ip u n c tu re  w hen  p re trea ted  w ith  
ion tophoresis ve rsu s EMLA cream . M ean p a in  scores fo r v en ip u n c tu re  p re  trea ted  
w ith  io n topho resis  w as over twice the m ean  p a in  scores for v en ip u n c tu re  follow ing 
trea tm en t w ith  EM LA. See Table 2 below .
Table 2. C o m p ariso n  o f  Pain  in  T reated  V en ip u n c tu res
z df P (sie) Sie Diff in  IV Pain
IV after Injection 
and  Ion tophoresis -2.03 2 .0422 (.02) N o
IV after In jection  
and  EMLA -.271 2 .7865 (.02) N o
IV afte r Io n to p h o resis  
an d  EMLA -2.38 2 .0176 (.02) Yes
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S um m ary  of R esults
Local A n esth es ia
T here  w as no  significant d ifference in  m ean  p a in  scores for tw o of the  th ree  
anesthetics adm in istered  w hen  com pared  to placebo. Both iontophoresis an d  its 
placebo a n d  EM LA cream  an d  its p lacebo w ere ra ted  low er in  p a in  experience w hen  
com pared  to  injection of lidocaine. T here  w as a significant d ifference in  pa in  
experienced  w ith  injection o f buffered  lidocaine an d  its p lacebo w hereby  buffered  
lidocaine w as ra ted  significantly low er in  pain  w hen  co m p ared  to  injection of sterile 
norm al saline. A pplication  o f EMLA cream  w as ra ted  the  m o st com fortable anesth ­
etic (M=1.5). Injection of b u ffered  lidocaine w as ra ted  the  least com fortable anesthe t­
ic (M=12.1), a n d  the m ean  pa in  score fo r iontophoresis fell in  the  m idd le  (M=6.3). 
V e n ip u n c tu re
T here  w as a  significant d ifference in  m ean  pa in  scores for ven ipunctures 
follow ing trea tm e n t w ith  aU anesthetics w hen  com pared  to m ean  pain  scores for 
v en ip u n c tu re  follow ing trea tm en t w ith  their placebo. T here  w as no significant 
difference in  m ean  pa in  scores w hen  com paring  v en ip u n c tu re  pa in  betw een  the 
three anesthe tics w ith  the  excep tion  in  com parison  b e tw een  ven ip u n c tu re  pa in  
follow ing ion tophoresis  and  v en ip u n c tu re  pain  follow ing EM LA cream  (p = .0176). 
The m ean  p a in  score for v en ip u n c tu re  follow ing ion tophoresis w as nearly  trip le  
that of the m ea n  p a in  score for v en ip u n c tu re  follow ing trea tm en t w ith  EMLA. The 
m ean p a in  score  for v en ipunc tu re  follow ing ion tophoresis w as tw ice as h igh as the  
m ean p a in  score for ven ipunc tu re  follow ing injection of lidocaine. A sum m ary  of 
all m ean  p a in  scores an d  the ir significance is found  in  Table 3 o n  the follow ing 
page.
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Table 3. Sum m ary  of Pain  E xperiences W ith  Local A nesthesia  an d  V enipuncture
T reatm ent 1 T reatm ent 2 T reatm ent 3
Injection Lidocaine Ion tophoresis L idocaine EMLA Cream  
(n = 20) (n  = 12) (n = 20)
PA IN  
(in  m m )
M SD P M SD P M SD P
T rea tm en t 12.1 11.4 6.3 12.4 1.5 4.0
.0020 .1070 .6800
Placebo 19.9 12.5 0.7 1.8 3.0 11.6
IV a fte r
A nesthetic 7.1 7.2 15.4 10.1 6.3 6.7
.0001 .0053 .0001
IV a fte r
Placebo 25.1 13.5 29.5 19.6 27.3 15.2
In  a  questionnaire, pa rtic ipan ts w e re  asked  w hich  of the  three types of local 
anesthesia , if any, they p re fe r for (1) them selves, an d  for (2) their child, if they or 
th e ir  ch ild  w ere ever to  u n d e rg o  v en ip u n c tu re?  In  considering  them selves, 58.8% 
chose EMLA cream  an d  41.2% chose in jection  o f buffered  lidocaine as their p referred  
m e th o d  o f p rep ara tio n  fo r v en ip u n c tu re . N o  p artic ipan t p refe rred  "no local 
anesthe tic"  p rio r to  ven ipunctu re . W h en  considering  their child, 94% chose EMLA 
cream  as their preference. Sim ilarly, no  p a rtic ip a n t chose "no  local anesthetic" p rio r 
to  th e ir child  u ndergo ing  ven ip u n c tu re . O ne  partic ipan t an sw ered  that he o r  she 
w o u ld  n o t p refer any  o f th e  local anesthe tics tested  in  this trial, b u t w ould  like 
"som e o th e r type" of anesthetic  fo r h is  ch ild  p rio r to undergo ing  venipuncture . N o 
p a rtic ip a n t selected ion tophoresis a s  a  p refe rence  fo r e ither them self o r their 
ch ild ren . H ow ever, on ly  12 p a rtic ip a n ts  u n d e rw e n t this in terven tion .
52
T oleration  of T reatm ents
T w en ty  ind iv iduals u n d e rw en t tw o treatm ents (4 ven ipunctu res and 2 
in trad erm al injections each), and  tw elve of these partic ipan ts  u n d erw en t three 
trea tm en ts  (tw o  add itiona l v en ipunc tu res  follow ing iontophoresis). Four 
ind iv idua ls  deve loped  m ild  echym osis (bruising) a t the v en ipunc tu re  site. One 
ind iv idua l d ev e lo p ed  m odera te ly  large echym osis b ilaterally  after the first trea t­
m ent. N early  all ind iv idua ls  (n = 12) receiving ion tophoresis developed  m ild red  
b lush ing  u n d e r  the  M ed itrode  w hich  lasted  several m inutes. This transien t 
sym ptom  is co n g ru en t w ith  the lite ra tu re  and  the m an u fac tu rer 's  w arning. It is 
difficult to d e te rm in e  if electrical cu rren t o r shearing  force d u rin g  rem oval of the 
h igh ly -adhesive  M editrode, o r both , is responsible for this sym ptom . Two 
ind iv idua ls  described  a  w arm , tingling, sensation  d u rin g  ion tophoresis at 3m A and  
requ ired  titra tio n  to 2mA and  l.Sm A m p before to leration. O ne indiv idual described 
an  uncom fortab le  sensation  u n d e r the  re tu rn  electrode even  a t 1.5 m A  and 
ion topho resis  w as d iscon tinued  at 7 m inutes. This ind iv idua l susta ined  the usual
L red  b lush ing  as described  in  the litera ture. N either this partic ipan t, o r  any others,
t
I developed  cu taneous b u m s o r o ther com plications re la ted  to  iontophoresis in this
study.
O ne in d iv id u a l developed  an  erythem ic, raised , rash, h ighly  pruritic,
I app rox im ate ly  15 m inu tes follow ing rem oval of EM LA cream  an d  T egaderm  patch.
This com pletely  reso lved  w ith in  one h o u r  w ith  no  sequelae. This w as the only case 
in  th is s tu d y  h igh ly  suspicious for tru e  allergenic reaction to e ither EMLA cream  o r 
the  T egaderm  dressing.
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CHAPTER FIVE 
DISCUSSION
Do patien ts receiving ven ipunctu re  w ish for pro tection  from  the d iscom fort 
of th is p rocedure? The resu lts  em phatically  dem onstra te  th a t all those partic ipa­
ting  in  this s tu d y  p re fe r a  local anesthetic  p rio r to  undergo ing  ven ipunctu re . N ot 
one  partic ipan t chose a p reference  for ven ipunctu re  w ith o u t p rep a ra tio n  w ith  a 
local anesthetic. H ow  d o  they  w ish  to have their ven ipunctu re  site  p repared?  
R oughly half of the partic ipan ts p referred  EMLA cream  (59%) a n d  half p referred  
injection of lidocaine (41%). If th e ir child w ere to undergo  venipuncture^ p a ren ts  
overw helm ingly  p refe rred  EM LA cream  (94%) to injection o r ion tophoresis of 
lidocaine.
As w as hypothesized , all th ree  local anesthetics p rov ided  significantly  m ore 
com fortable ven ipunctu res, an d  in  som e cases, com pletely pain less ven ipunctu res
p (n = 10) w hen  using a local anesthetic  beforehand. These findings a re  su p p o rted  by
I the  litera ture  (H arrison e t al., 1992; Dickey, 1988; S teinbrook e t al., 1993).
I
% In this study , b o th  EM LA cream  and  injection of lidocaine resu lted  in  abou t the
I sam e degree of relief from  v en ip u n c tu re  pa in  w ith  their m ean  p a in  scores being
i
 ^ low , 6.3m m  an d  7.1m m  respectively . This is consisten t w ith  the  pa rtic ipan ts  selec-
I ted  anesthetic  preferences for EMLA cream  an d  injected lidocaine. Iontophoresis of
lidocaine also p ro v id ed  significant relief fi-om ven ipunc tu re  p a in  b u t  n o t to the
I sam e degree as its com petito rs. M ean ven ipunctu re  pa in  after ion tophoresis w as
15.4mm. This too is consisten t w ith  the partic ipan ts hesitancy to  select ion tophor-
\
: esis of lidocaine as an  anesthetic  preference. Therefore, these find ings do  no t
su p p o rt the  th ird  hypo thesis of this s tudy  w hich pro jected  ion tophoresis to be the 
p referen tia l local anesthetic.
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Just h o w  pain fu l is the  adm in istra tion  of each of the local anesthetics? EMI.A 
cream  scored  low est in  p a in  (m  = 1.5mm), iontophoresis fo llow ed (m  = 6.3mm), and  
injection scored  h ighest in  p a in  (m =  12.1mm). Yet, nearly  ha lf of th e  participants 
(41%) chose in jection  as th e ir p re fe rred  anesthetic. This cu rious find ing  m ay be 
exp la ined  by in jected  lidocaine 's  effectiveness in  a tten u a tin g  IV p a in . A fter all, 
m ean  v en ip u n c tu re  p a in  a fte r p lacebos for injection, ion tophoresis, an d  EMLA w ere 
25.1mm, 29.5m m , a n d  27.3m m  respectively. The tradeo ff then , w as to  experience 
a m ean  p a in  level of 12.1mm w ith  injection of lidocaine to  forego as m uch  as a 
m ean  p a in  level of 29.5m m  for ven ipunctu re  w ith o u t anesthesia . T h is am ounts to 
qu ite  a  significant sav ings from  pain . In actuality, the  very  h ighest p a in  score for a 
ven ipunc tu re  a fte r any  p lacebo w as 61.0m m  and  the  very  low est p a in  score for 
injection o f lidocaine w as 0.0m m , therefore  the tradeoff in  pa in -sav ings for IV 
p u n c tu re  can  be  in d eed  g rea te r even  w h en  adm in istering  th e  "m o st uncom fortable" 
of the local anesthetics.
W hy v en ip u n c tu re  p a in  follow ing iontophoresis of lidocaine ten d e d  to be tw o 
to th ree  tim es g rea te r th an  th a t of its ' associates m ay be exp lained  by  the m ethodolo­
gy of adm in istra tion  o f ion tophoresis. In this study , a  m ean  of 8.07 m inu tes of 2.9 
m A  w as de livered  in  con ten tion  for tim eliness and  effectiveness of th is  treatm ent. 
P rio r stud ies have  rep o rte d  effective anesthesia w ith  these p a ram eters . Coats and 
L up in  (1993) fo u n d  accelerating  d ep th s in  com plete anesthesia  of d e rm is  u p  to 7.5 
m inu tes of app lica tion  in  7  ad u lts  w hich  p la teaued  a t 9 m inu tes app lica tion  time. 
Benefits to anesthesia  d e p th s  sharp ly  declined w ith  add itional app lica tion  beyond 10 
m inutes. M aloney e t al., (1992) app lied  a m ean  m A  of 3.4 for a m ean  d u ra tio n  of 8 
m inu tes to 24 subjects w ith  resu lts  dem onstra ting  com plete  anesthesia  in  80% of 
need le  pu n c tu res . H ow ever, 4% lidocaine w ith  ep inepherine  w as u se d  in  this 
s tudy . Russo e t al., (1980) app lied  2 to 4 m A  over 7 m inu tes to  12 vo lun teers. These
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ind iv idua ls then  received full-thickness su tu res at the  trea ted  site. O nly one 
partic ipan t repo rted  a du ll sensation  d u rin g  suturing.
Perhaps an  app lica tion  tim e of 10 m inutes o r m ore m ay have p ro v id ed  results 
reflecting g rea te r anesthesia  and  low er m ean  pain  scores fo r v en ip u n c tu re  following 
ion tophoresis as has has been  described  in  o ther lite ra tu re  (G reenbaum  &
Bernstein, 1994; Z eltzer e t al., 1991; A rv idsson  et al., 1984; Petelenz e t al., 1982).
A no ther considera tion  in  the  popu larity  of EM LA a n d  injection versus 
ion tophoresis reg a rd s the  observation  th a t som e partic ipan ts in  th is s tudy  verbal­
ized  inconvenience w hile  sitting  for iontophoresis of lidocaine for approxim ately  8 
m inu tes. In com parison , the  o n e -hou r absorp tion  requ irem en t for EMLA cream  
m ay  have gone unno ticed  by  partic ipan ts as EMLA cream  w as app lied  to the  
p a rtic ip an ts  by  m om en tarily  (abou t one m inute) in te rru p tin g  their rou tine  a t their 
w o rk  location. A lthough  ENILA cream  requires a one h o u r tim e com m itm ent and 
ion tophoresis requ ires only ab o u t 8 m inu tes, rou tines m ay con tinue  w hile aw aiting 
EMLA cream  to take ho ld  w hereas rou tines come to a  halt w hile recip ien ts are 
a ttach ed  to the  ion tophoresis un it. P opu larity  for injection of lidocaine, desp ite  
[ a n o th e r need le  prick, m ay be a ttrib u ted  to the convenience of th is effective local
anesthetic , typically tak ing  one  m inu te  o r  less.
R elationship  of the  F ind ings to  the Theoretical F ram ew ork
Betty N eu m an 's  System s T heory (1989) and sensory pain  theories served  as 
theoretical fram ew orks for th is s tudy . N eum an  believes th a t each ind iv idua l or 
clien t-system  is in te rconnected  w ith  in te rnal an d  ex ternal env ironm en ta l forces 
w h ich  from  tim e to  tim e becom e sources of noxious stim uli o r stressors. C onten­
d in g  w ith  stressors consum es a  p o rtio n  o f the  ind iv idua l's  finite energy  reserves 
h av ing  the  p ro p en sity  to  m ove the  client-system  aw ay from  hom eostasis or
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wellness. T he goal of nursing is to strategically  in tervene to elim inate o r  red u ce  the 
negative im pact of stressors u p o n  the client-system  in order to conserve the 
in d iv id u a l's  energy  an d  m ain tain  a  m axim um  level of wellness.
Is pa in  from  venipuncture  a stressor w arran ting  in terven tion  by nursing?
All of the partic ipan ts  in  this study  th o u g h t so. All participants chose to  hav e  som e 
form  of local anesthetic  if they w ere  ever to  u n d e rg o  ven ipunctu re  again. Sim ilarly, 
cill o f the  partic ipan ts chose to have a local anesthetic  for their child  if he o r  she w ere 
to u n d e rg o  ven ipunc tu re .
The rou tine  p rocedure  of ven ipunctu re  m ay be m ore im p o rtan t to pa tien ts  
than  w e have apprecia ted . In a s tudy  by T u ttle  (1997) exam ining w hat pa tien ts  
believe to  be the  m ost im portan t "caring" behav io rs by nursing, "know ing  h o w  to 
give IV 's" w as ra te d  second on  a list of 63 n u rse  caring behaviors (W atson, 1985). 
These results substan tia ted  a study  by  C ron in  a n d  H arrison (1988) an d  L arson  (1984)
' w hich identified  n u rses ' adeptness for caring for IV 's to again be one of the  m ost
I essential n u rsing  responsibilities. It is u n k n o w n  w hether pa tien ts have cen tered  on
f nu rsin g 's  ro le in  ven ipunctu re  because of fear o f com plications from  an  im p ro p -
I erly p laced  TV o r because of fear of g rea ter p a in  w ith  an inexperienced o r unskilled
C
i cannulator. It is possib le  both  concerns have  lead  to patients ra ting  TV's as the
I second m ost im p o rtan t nurse  caring behav io r in  T uttle 's study . These find ings are
i congruen t w ith  H am ilton 's  (1994) citation fo r the  new  m edical diagnosis, "needle
f
i phobia" affecting a n  estim ated 10% of the popu la tion . V enipuncture appears  to be a
[ g rea ter concern  an d  p>otential stressor to  pa tien ts  than  we had  judged .
\ W ould e lim ination  of ven ipunctu re  p a in  resu lt in g rea ter energy a n d  coping
by patien ts for o th e r stressors they m ay face? A lthough  d irect m easu rem en t for this 
m ay be im probable, w e know  pa in  to be taxing. D iagnostic and  p rocedural p a in  in  a 
hospital setting  w here  individuals are  a lready  faced w ith o ther adversities, m ay tax
57
ind iv iduals a t an  even  h igher rate. T herefore, e lim inating  p rocedura l pa in  m ight 
reap g rea ter energy  savings in this setting. It is no tew orthy  th a t all indiv iduals in 
this s tudy  w ere  free from  acute o r chronic illness, ye t all still p referred  to have their 
v en ip u n c tu re  p a in  a tten u a ted  w ith  a local anesthetic.
The im plications for nursing  seem  clear. T he findings of this s tudy  su p p o rt 
w ell-docum ented , nearly -unan im ous clinical tria ls establish ing  the  safety and 
efficacy of lidocaine as a  local anesthetic for ven ipunctu re . W hat m ay  be lacking 
how ever, are clin ician 's w illingness to  acknow ledge ven ipunc tu re  pa in  as a stressor 
for pa tien ts an d  w illingness to m ake the  changes in  clinical practice necessary to 
alleviate this stressor.
S treng ths, L im itations, a n d  R ecom m endations
This study  m ay stand  alone in  that to  th is researcher's  know ledge, there exist 
no o ther trials m easuring  to leration  of th ree  d iffe ren t local de livery  m ethods for 
 ^ lidocaine as w ell as placebos in  one sam ple. T he s tu d y  is fu rther un ique  in  that
I these sam e ind iv idua ls w en t on  to u n d erg o  v en ip u n c tu re  follow ing each d ifferent
 ^ anesthetic trea tm en t as w ell as placebos for each. The g ro u p  w as then  given an
! opportunit}/^ to express w h ich  treatm ent, if any, w as p refe rred  for them selves and
? their children. A B onferonni correction w as app lied  in  th is analysis p rov id ing
; m ore rigorous estim ation  of the true  p robab ility  of erroneously  conclud ing  a
Î com parison to be significant. Therefore, there  is g rea ter confidence in  the significant
 ^ differences found  in  this s tudy .
I This s tudy  is very  lim ited by the sm all vo lun teer sam ple u tilized . H ow ever,
; the  num ber of pa rtic ipan ts in  this s tudy  is consisten t w ith  the  n um ber of subjects
found  in  sim ilar trials w h ere  vo lun teers a re  asked  to  subject them selves to painful 
experim ental in te rven tions. N onetheless, the  resu lts  of th is s tu d y  canno t assuredly
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be generalized  to the public. The partic ipan ts of this s tu d y  w ere from  m edical and  
param edical professions w hich  w ou ld  be expected to bias the resu lts of this study  as 
well.
It is recom m ended  th a t fu rth e r clinical trials com pare the  safety an d  
effectiveness, as well as the  pub lic 's  w ishes, regard ing  local anesthesia  before 
ven ipunctu re . Larger, ran d o m ized  sam ples will lend  credence to  ex isting  research. 
E xam ination of the th ree  m odalities shou ld  be expanded  to  include  anesthesia  
before o th er hospital o r o u tp a tien t p rocedures w hich  are  know n  to be  painfu l, bu t 
have historically gone u n trea ted . C u rren t research has so em phatically  identified  
ven ipunctu re  pa in  to be relieved by  anesthetic  trea tm en t, w h en  com pared  to 
placebo, fu tu re  stud ies m ay consider elim ination of placebo, in  o rd e r to  zero  in on 
s tu d y  for m ore efficient uses of ex isting  and  new  m odalities of local anesthesia.
The safety and effectiveness of EM LA cream  for ven ipunctu re  in  ch ild ren  has 
been  established in  d e p th  in  the lite ra tu re . Further stud ies are  called for to  expand 
beyond  the  superio r qualities o f EM LA cream  to exam ine the  d isadvan tages of 
EMLA cream , specifically the tim eliness requ ired  (one hour) fo r onse t of derm al 
anesthesia. Sonophoresis is being  s tu d ied  as a po ten tia l m echanism  of u ltrasound- 
enhanced  transderm al d ru g  delivery  an d  m ay p rove to  accelerate the effects of 
topical anesthetics such as EM LA cream  (Bom m annan, e t al., 1992).
C o n c lu sio n
The results of this s tu d y  show  th a t the three com m on reasons g iven  by 
clinicians for n o t using a local anesthe tic  p rio r to ven ipunc tu re  a re  invalid .
V enipuncture  has been  show n  to be a stressor for pa tien ts  for w hich  they  desire 
relief. A dm in istra tion  of the  local anesthe tic  lidocaine, w h e th er g iven  by  injection,
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iontophoresis, o r topically , is far less painfu l than  ven ipunc tu re  itself. All three 
m ethods of de livery  of lidocaine have  been docum ented  in  the  lite ra tu re  to be safe 
in adu lts  to w hich  th is s tu d y  can add .
EMLA cream  d em o n stra ted  superiority  over injection an d  ion tophoresis of 
lidocaine. EMLA w as the  m ost com fortable anesthetic trea tm en t, it p ro v id ed  for the 
m ost com fortable v e n ip u n c tu re , an d  it w as overw helm ingly  chosen  p referen tia l by 
the partic ipan ts w h e n  considering  ven ipunctu re  in  ch ild ren  a n d  so m ew h at p refer­
ential over in jection of lidocaine w h en  considering them selves.
The findings of th is s tu d y  as well as the rev iew  of the  lite ra tu re  p resen ted , 
su p p o rt the use of EM LA cream  an d  injection of lidocaine as local anesthetics in 
e lim inating  the  p a in  of v en ip u n c tu re . Further investigation  in to  p rac ticality  an d  
effectiveness of io n to p h o resis  as an  anesthetic  for ven ipunc tu re  will likely reinforce 
iontophoresis to b e  an  effective m odality  on  the  m enu  of pa in -re liev ing  m easures.
This researcher suspects th a t the  added  tim e and cost in  offering pa tien ts  a 
local anesthetic  befo re  v en ip u n c tu re , wiU continue to  eiUow ra tio n a liza tio n  by 
clinicians and  in stitu tions against the  use of a local anesthetic. W ithou t organized  
advocation  by  a profession , the  unsuspecting  public will be pow erless to  insist on 
this h idden  and  h u m an e  clinical practice.
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A ppendix  A 
Visual A nalog Scales
Please place a single m ark  u p o n  the  line w hich  rep resen ts the  am o u n t o f p a in  you 
experienced w ith  each p ro ced u re . The left m argin  of the line rep resen ts  no  pa in  at 
all and  the right m argin of the  line  represen ts w orst pain.
M eeting #
-
NO PAIN MILD PAIN MODERATE PAIN WORST PAIN
NO PAIN MILD PAIN MODERATE PAIN WORST PAIN
NO PAIN MILD PAIN MODERATE PAIN WORST PAIN
NO PAIN MILD FAIN MODERATE PAIN WORST PAIN
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A ppendix B 
Q uestionnaire
Please select one answ er for each question  by  placing a  check m ark  by  y o u r  answ er.
A. W hich of the  th ree  delivery m ethods for the local anesthetic  lidocaine, d id  you  
prefer?
1 .____  In jection  of lidocaine (m eeting  #1)
2 .____  Io n to p h o resis  of lidocaine (m eeting  #2)
3 .____  Topical app lication  of EMLA cream  (m eeting  #3)
4 .____  I d id  n o t care for any of the above local anesthetics, bu t I w ou ld  like to
have m y a rm  num bed before ven ipunctu re
5 .____  I do  n o t w ish  to receive a local anesthetic  befo re  undergo ing  v en ip u n c tu re
If y o u r ch ild  w ere  to  undergo  ven ipunctu re , w hich m eth o d  of local anesthesia  
j w ould  y o u  p refe r for him  or her to  receive?
; 1.____  In jection  of lidocaine
I^
 2.____  Io n to p h o resis  of lidocaine
[ 3._____ T opical app lication  of EMLA cream
I
4.  I d o  n o t w ish  my child to receive any of the  above local anesthetics, b u t  I
? w o u ld  p refe r m y ch ild 's  a rm  to  be num bed  before undergoing  veni-
; punctu re .
I
I 5._____ I d o  n o t w ish  for m y child  to recieve a local anesthetic  before u n d erg o in g
[ v en ipunc tu re
I
i  Please answ er:
■ M ale   F e m a le____
A g e _____
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A ppendix C 
C onsent Form
THIS IS A PROSPECTIVE STUDY TO DETERMINE THE EFFECTIVENESS, IF ANY, OF 
INTRADERMAL LIDOCAINE COMPARED WITH LIDOCAINE BY lONOPHORESIS, 
COMPARED WITH TOPICAL LIDOCAINE/PRILOCAINE CREAM AS LOCAL
ANESTHETICS IN VENIPUNCTURE 
PRINCIPAL INVESTIGATOR: Carol Straight, R.N.
PURPOSE: 1 AM BEING ASKED TO PARTICIPATE IN A RESEARCH STUDY INVOLVING:
1) THE ADMINISTRATION OF THE DRUG LIDOCAINE (1% CONCENTRATION) 
UNDER MY SKIN BY INJECTION AND BY PROPULSION OF LIDOCAINE (2 % 
CONCENTRATION) UNDER MY SKIN, AND BY DIFFUSION OF LIDOCAINE/ 
PRILOCAINE CREAM TOPICALLY (CONCENTRATION OF 5%) UNDER MY SKIN, 
PRIOR TO VENIPUNCTURE WITH A 20 GAGE IV CATHETER FOLLOWING EACH 
TREATMENT FOR A TOTAL OF SIX TV STARTS ( TWO IV STARTS O N  THREE 
SEPARATE OCCASIONS
2) COMPLETE A PAIN ASSESSMENT SCALE AND THREE QUESTIONS REQUIRING 
ONE TO FIVE MINUTES
It has been  explained  to  m e tha t L idocaine a n d  Prilocaine are  d ru g s  w idely  used  as a 
local anesthetic. L idocaine and  Prilocaine, ad m in is te red  in  this s tu d y , a re  s tan d a rd  
concentrations and  am o u n ts , safely p rov id ing  local anesthesia  o f a su rface  area  
approxim ately  tw o cm  in  d iam eter for approx im ate ly  30 to  60 m inu tes. Allergic 
reactions to Lidocaine and Prilocaine have been  know n to occur on  rare occasion. 
Sensitivity or allergic reactions can range from brief redness and itch ing o f the sk in  
to difficulty breathing. I understand that if  I have a know n allergy or sensitiv ity  to 
Lidocaine or Prilocaine, I caim ot participate in  th is  study. I also understand that if  I 
am currently taking a Sulfa m edication, I cannot participate in th is study. In 
addition, I understand that if  I have a major or chronic illn ess, I am pregnant, I have  
a pacemaker or automatic im plantable defibrillator, or 1 have a condition called  
Glucose-6-Phosphate D ehydrogenase D eficiency, I cannot participate in th is study  
The purose  of this research  study  is to de te rm ine  w h e th er the pa in -reducing  effects 
of Lidocaine so lu tion  a n d  lidoca ine / p rilocane c ream  can be app lied  effectively in  
venipuncture . A pprox im ately  tw enty-five vo lu n teers  w ill be so u g h t fo r th is s tudy .
PROCEDURE:
If I agree to partic ipa te  in  this research study , the  follow ing will b e  expec ted  of m e.
1) M eeting #1: Receive an  in traderm al in jection of O.Scc of 1% lidocaine  in to  the 
righ t o r left fo rearm  follow ed by  p lacem ent of a 20 g  Insyte IV catheter.
Receive an  in trad erm al injection of 1 cc of sterile norm al saline in to  the  righ t 
or left forearm  follow ed by placem ent of a  Insyte 20 g  IV catheter.
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Approxim ately 1 w eek  la ter  
M eeting # 2: Receive a needleless in jection of 2% lidocaine using  a sm all 
and  usually undetectab le  electrical cu rren t (1.5-3mAmps) fo r approx im ate ly  
eight m inutes in to  the righ t or left forearm  follow ed by p lacem en t of a  20 g 
Insyte IV catheter. Receive a needleless in jection of norm al saline using  
the sam e technique follow ed by  p lacem ent o f a 20 g Insyte IV catheter.
Approxim ately 1 w eek  la ter  
M eeting #3: Receive topically 2.5 g  of EM LA cream  (lidocaine 2.5% and  
prilocaine 2.5%) u p o n  abou t a  2 inch  by  2 inch  surface a rea  o n  the rig h t o r  left 
forearm  follow ed by placem ent of a clear occlusive d ressing  p laced  over the 
cream . The d ressing  and  cream  w ül be com pletely  rem oved  1 h o u r  la ter an d  
a  20 g Insyte IV catheter inserted . Receive topically an  u n m ed ica ted  cream  
u p o n  about a 2 inch  by  2 inch surface area  o n  the right o r  left fo rearm  follow ed 
by  placem ent o f a clear occlusive dressing  p laced  over the  cream . The dressing 
an d  cream  will be  com pletely rem oved  1 h o u r  later an d  a  20 g  Insyte IV 
catheter will be inserted .
2) C om plete a visual p a in  scale a fte r each ven ipunctu re  req u irin g  approx im ate ly  
one to two m inutes and  com plete three questions after tiie th ree  trea tm en ts
3) Removal of each IV catheter a n d  p lacem ent o f a bandaid  to be rem oved  in  2 
hours
4) O bserve the ven ipunctu re  site fo r 24 hours from  p rocedu re  a n d  contact
the researcher if the follow ing sym ptom s shou ld  occur: sw elling o r redness 
a t the site, itching o r p a in  a t the site, a  rash  a t  the site o r e lsew here, o r  any 
new  or unusual sym ptom s.
5) I  understand  tha t I w ill be contacted  by  the researcher app rox im ate ly  24 hours 
after each m eeting in  evaluation for side effects.
RISKS/BENEFITS:
Very rarely, ind iv iduals m ay be allergic o r  sensitive to L idocaine o r  Prilocaine. 
Sym ptom s of allergy can range  from  n ü ld  redness o r itching a t th e  site to  difficulty 
breath ing .
The resu lts o f this study  m ay help  clinicians to iden tify  L idocaine a n d  L idocaine 
/  Prilocaine cream  as a safe an d  effective local anesthetic  for the p ro ced u re  of 
v en ipunc tu re .
M y participation  in  this s tu d y  is vo lun tary . N o p ay m en t for p a rtic ip a tio n  w ill be 
given . I u n ders tand  th a t in  the  even t o f in ju ry  o r  illness resu lting  h o rn  the  study , 
no  com pensation, free m edical care o r re im bursem en t is offerred  by G ran d  Valley 
State U niversity  o r by the researcher. I u n d e rs tan d  th a t I am  free to w ith d raw  my
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consen t to partic ipa te  in this research  s tu d y  a t  any  time and  for any reason.
CONFIDENTÏAUTY;
I u n d e rs ta n d  th a t m y partic ipa tion  in  th is research  stu d y  is strictly confidential.
The reco rds of the study  will be  k ep t b y  the  researcher and  will be shared  w ith  only 
key n u rsin g  faculty of G rand  V alley S ta te  U niversity . The results of the s tu d y  m ay 
be sh a red  w ith  g roups and  o rgan izations and  m ay even be published . H ow ever, 
no in fo rm ation  by  w hich I m ay be iden tified  w ill be  released o r published .
In the  ev en t I requ ire  m edical care as a  resu lt o f th is research study , details of the 
research  s tu d y  m ay be released to  the  ind iv idual(s) involved in  m y care.
I have rea d  or have had  read  to  m e all the  above inform ation  abou t this research  
study , includ ing  the research p rocedu re , possible risks and  side effects, a n d  the 
likelihood of benefits from  the study .
The co n ten t an d  m eaning of th is in fo rm ation  has been  explained a n d  is u n d e rs to o d  
by m e. All o f m y questions have been  answ ered . I hereby consent and  vo lun tarily  
offer to follow  the study  requirem ents an d  take p a r t  in the study. I u n d e rs tan d  th a t I 
will receive a signed copy of this consen t form .
If I h av e  any  questions concerning m y partic ip a tio n  in this s tu d y  now , o r  in  the  
fu tu re , I m ay  conatct Carol S traight, R.N. a t (616) 938-1165 o r Professor Paul 
H uizenga a t (616) 895-2472.
R e s e a rc h  P a r t i c ip a n t 's  N a m e _________________________________________
R e se a rc h  P a r t ic ip a n t 's  H o m e  P h o n e  #________________________________
R e s e a rc h  P a r t i c ip a n t 's  S ig n a tu r e ______________________________________
D a t e  S i g n e d ______________________________
W i t n e s s ___________________________________________________________________
D a t e  S i g n e d ______________________________
I am  in te res ted  in  receiving a  su m m ary  o f the  s tu d y  results. Yes  No_
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A ppendix  D
Life-Tech, Inc.
10920 Kinghurst • Houston. TX 77099 
713-195-9411 • Fax: 713-195-7960 • 1-800-231-9841
NeedleBuster® Setup Chart 
Meditrode (6570) and Gel-Trode (6585)
Age 0-2 Yrs. 2-6 Yrs. 6-t- Yrs. / Patient 
Comfort Level
Current .5 1 2 3 4
Time 20 15 10 7.5 5
Meditrode Fluid 
Capacity
Bandaid 
6570S 
1.5 CC
Small Square
6570M
2CC
Large Square
6570L
7C C
Roimd Return
6570R
6C C
Skin Preparation
1. Inspect site for skin imperfections.
Caution: Do not place electrode o\ er skin imperfections such as moles, scars. %3rts. or damaged skin. If can not be 
avoided, insulate damaged area b> applying Vaseline with a Q-tip over imperfection only. Clip excessive hair if 
necessaiy . Do not shave treatment area within 24 hours before treatment.
2. Wipe with alcohol sw-ab and let drv 
Caution: Do not abrade
|6570(.\)| |6585(xx)Meditrode ^iplication
1. Remove backing firom 6570(x)Meditrode®
2. Apply to clean & dry treatment area, slightly stretching while applying to remove all wrinkles
3. Coimect the red NeedleBuster lead wire to the active drug delivery Meditrode® (6570 series)
4. Remo\ e backing from the 658S(xx) self adhering dispersive Gel-Trode
5. Apply to clean & dr> treatment area starting firom the center and pressing towards the end to smooth all wrinkles
6. Coimect the black NeedleBuster® lead wire to the self adhering dispersive Gel-Trode
7. Satiuate the 6S70(.\)active drug delheiy Meditrode with drug solution b> placing the syringe tip into the fill ports and
injecting fluid until electrode saturation is achieved.
Meditrode Bandaid Small Square Large Square Round Return
Fluid 6570S 6570M 6570L 6570R
Capacirv 1.5 CC 2CC 7C C 6C C
NeedleBuster ® Coimection
1. Connect leads to NeedleBuster® In* coimecting the read lead to the red connector labeled “Drug (-t-)' and the black lead 
to the black cormector labeled “RTllN (-)"
2. Turn on NeedleBuster®b>’ pressing the ke>’ pad labeled “On/OBT and observing that the “PWR” light is on and the 
“OPN” light is off. If “OPN” occurs, consult NeedleBuster operating manual.
3. Set Current as shown above b) rotating Current knob clockwise to increase delivery time and counter clockwise to 
decrease deliver} time
4. Set Time as shown above bv rotating Time knob clockwise to increase delivery time and counter clockwise to decrease 
delivery time.
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A ppendix  E
A stra P harm aceu tica l Insert In struc tion  for the  Use o f EMLA Cream
£AUAO
C R E A M  (lidocaine 2.5% 
and prilocaine 2.5%)
1 •  Apply 2.5 g of cream 
(1/2 the 5 g lube) per 20 
to 25 cm' (approx. 2 In. 
by 2 In.) of skin In a  thick 
layer at the site of the 
procedure.
JL* Take an occlusive 
dressing (provided with the 
5 g tubes only) and remove 
the center cut-out piece.
0 «  Peel the paper liner 
from the paper framed 
dressing.
(Instructions continued on 
reverse side.)
4 #  Cover the EMI.A" 
Cream so that you get a 
thick layer underneath. Do 
not spread out the cream. 
Smooth down the dressing 
edges carefully and ensure It 
Is secure to avoid leakage. 
(This Is especially important 
when the patient is a  child.)
3 #  Remove the paper 
frame. The time of application 
can easily be marked directly 
on the occlusive dressing. 
EMLA* must be applied at 
least 1 hour liefore the start 
of a routine procedure and for 
2 hours ttelore the start of a  
painful procedure.
O a  Remove ttie occlusive 
dressing, wipe off the EMLA* 
Cream, clean the entire area 
with an antiseptic solution and 
prepare the patleiu for the 
procedure. The duration of 
effective skin anesthesia will be 
at least 1 hour after removal of 
the occlusive dressing.
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